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1 INTRODUCTION 
Vitamin B12 inarguably has been one of the most complex and fascinating molecules in 
the world of science and medicine. The vitamin was accidentally discovered in the 
early 1920s, when it was demonstrated as the cure of pernicious anaemia. As the last 
vitamin to be isolated, the water-soluble vitamin has the most complex structure and 
the largest molecular mass (1335-1580 Da) (Martens et al. 2002; Truswell 2007), 
consisting a planar ring system with cobalt as central atom, a lower (alpha) ligand and 
an upper (beta) ligand. Over the span of more than 90 years, much has been revealed 
about the vitamin that was previously described as ‘frighteningly complex’. Yet, many 
missing pieces in the whole vitamin B12 saga are still waiting to be found, particularly 
vitamin B12 production in plant-based food system.  
In the metabolism of mammalian cells, vitamin B12 is required to assist two enzymatic 
activities; methionine synthase and (R)-methyl-malonyl-CoA mutase. Methionine 
synthase is involved in the DNA synthesis. While (R)-methyl-malonyl-CoA mutase 
requires vitamin B12 in the catabolism of odd-chain fatty acids, certain amino acids and 
cholesterol. When vitamin B12 is lacking, the level of homocysteine increases, posing a 
major risk for heart disease, atherosclerosis, stroke and vascular disease. Uniquely, the 
biosynthesis of vitamin B12 exists only in some bacteria and archaea. Although animals 
(including humans) and protists require vitamin B12, they do not synthesize it. The 
vitamin is thus available only in foods fermented or contaminated by such bacteria or 
in the tissues of animals fed by vitamin B12-containing feed. Hence, humans obtain 
vitamin B12 by mainly consuming animal-derived products.   
Due to their diet, vegetarians and vegans are highly prone to vitamin B12 deficiency. 
Since vitamin B12 takes part in DNA synthesis, deficiency hinders cell nuclei division 
that affects blood cell formation, resulting megaloblastic anaemia. In severe vitamin 
B12 deficiency, neuropathy diseases such as dementia and Alzheimer’s can also occur. 
Nevertheless, the trends toward vegetarianism and veganism have been rising due to 
the increasing awareness of health (Campbell et al. 1998; Daviglus et al. 2008), 
sustainability issues and animals welfare. To meet the recommended amount (the 
lowest requirement of any known essential nutrients) at 2.4 µg/d (the Institute of 
Medicine, 1998), vegetarians and vegans are required to consume fortified foods and/or 
vitamin  B12 supplements. However, the recent trends also show that the consumers 
prefer natural and food grade products to supplements in tablet form. Therefore, more 
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studies (Hugenholtz and Smid 2002; Hugenholtz 2008; LeBlanc et al. 2011; Capozzi et 
al. 2012) have been carried out to produce vitamin B12 directly in the food system 
utilizing food-grade microorgansims, called in situ vitamin production. Besides 
providing vitamin B12 in foods through natural enrichment, in situ fermentation is more 
cost effective and environment-friendly as chemical processes in the commercial 
vitamin  B12 production such as extraction, purification and crystallization can be 
omitted.  
Despite the opportunities to produce vitamin B12 through in situ fermentation, plant-
based fermented foods that contain naturally synthesized vitamin B12 are still limited. 
Previous studies mostly covered the vitamin B12 production in tempe/tempeh, an 
indigenous product of fermented soybean from Indonesia (Liem et al. 1977; Okada 
1989; Keuth and Bisping 1993, 1994; Wiesel et al. 1997). In addition, published results 
on production of vitamin B12 by Propionibacteria (one  of  the  highest  vitamin  B12-
producing bacteria) in plant-based foods does not exist although it has potential 
applications in enriching plant-based foods with vitamin B12. Thus, this study aimed to 
investigate the requirement of different precursors in the vitamin B12 biosynthesis in 
optimal media conditions and then in cereal matrices using strains of P. freudenreichii. 
The study also investigated any differences of vitamin B12 production among the strains 
of P. freudenreichii with respect to the added precursors.  
To understand the complexity and the importance of vitamin B12, the literature review 
started with the sophisticated structure of vitamin B12 and the availability of vitamin 
B12 in  certain  foods.  The  review  was  followed  by  how  vitamin  B12 plays important 
roles in human metabolisms and how a human body transports and absorbs the vitamin. 
The biosynthesis of vitamin B12 and the formation of the lower ligand 5,6-
dimethylbenzimidazole (DMBI) were also explained, followed by the coverage of 
recent studies in optimizing vitamin B12 production using plants and waste media. In 
the next part of the thesis, the methods to prepare the cultures and produce vitamin B12 
with various treatments were clearly described. The vitamin B12 quantification was 
done by using microbiological assay (MBA) and a newly developed UHPLC method 
(Chamlagain et al. submitted). The final parts of the thesis presented the results and the 
discussions  on  the  effects  of  adding  different  precursors  and  varying  the  timing  of  
adding the precursors on vitamin B12 concentrations.     
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2 LITERATURE REVIEW 
2.1 History 
The importance of vitamin B12 in medical and scientific world was accidentally 
acknowledged in the early 1920s, when it was demonstrated as the cure of a gastric 
autoimmune disease, pernicious anaemia. The firstly recorded experiments were 
performed by an American physician, George Hoyt Whipple, who intentionally bled 
dogs to induce anaemia. He later fed them with various diets to find the most 
effective food that brought haemoglobin level back to normal. The result showed that 
large consumption of pig liver allowed the fastest recovery (Whipple 1927; 
Robscheit-Robbins and Whipple 1929). Hence, Whipple hypothesized that liver 
consumption might treat pernicious anaemia (Whipple 1934). 
The notable progress in finding the cure of the disease was contributed by the other 
two American physicians; George Richards Minot and William Parry Murphy (1926). 
After several clinical studies, they isolated some substances in the liver and 
discovered iron was the cure of anaemia in dogs. However, they later also found 
different liver substance, called “extrinsic factor” that cured pernicious anaemia in 
humans. Albeit  this finding, the patients were still  treated with high consumption of 
raw liver or liver juice. In 1934, their discoveries concerning liver therapy in cases of 
anaemia rewarded Minot and Murphy (together with Whipple) Nobel Prizes in 
Physiology or Medicine. 
For the next 20 years, the identification of the extrinsic factor was still obscure, until 
some chemists sponsored by pharmaceutical companies isolated a red crystalline 
compound from liver juice that was used to treat pernicious anaemia. Mary Shaw 
Shorb (1947, 1948) and Karl August Folkers (Rickes et al. 1948) in collaborative 
project with Merck developed Lactobacillus lactis Dorner  (LLD)  assay.  The  LLD  
assay achieved rapid isolation of the extrinsic factor leading to its purification and 
characterization. Simultaneously, British researchers, E.L. Smith at Glaxo, and 
Alexander Robertus Todd performed the same experiment (Smith 1948a, 1948b, 
1952). The red crystalline compound was later named vitamin B12. 
It took several years later when Dorothy Crowfood Hodgkin and her team specified 
the three-dimensional structure of vitamin B12 (cyanocobalamin) and, 5 years later, 
coenzyme B12 (adenosylcobalamin) based on X-ray crystallographic data (Hodgkin et 
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al. 1954, 1956, 1957; Lenhert and Hodgkin 1961). Since then, other forms of vitamin 
B12 and pseudo-vitamin B12 have been discovered.  
2.2 Structure and Forms of Vitamin B12 
Vitamin B12 was the last vitamin to be isolated. Amongst of vitamins, it has the most 
complex structure and largest molecular mass (1335-1580 Da) (Martens et al. 2002; 
Truswell 2007). The water-soluble vitamin covers various polycyclic compounds of 
the cobalamin group, whose molecules can be characterized into three parts (Figure 
1):  a  planar  ring  system with  cobalt  as  central  atom,  a  lower  (alpha)  ligand  and  an  
upper  (beta)  ligand.  The  planar  ring  system consists  of  four  pyrrole  units  (A,  B,  C,  
and D, Figure 1) forming cobyrinic acid hexaamide (cobyric acid, factor V1a). The 
alpha ligand is supplied by the N7-atom of 5,6-dimethylbenzimidazole (DMBI), 
which is additionally linked to the propionic acid chain of cobyric acid via D-1-
amino-propanol-2 and phophoribose, forming nucleotide loop. In some anaerobic 
bacteria, the alpha ligand is replaced by adenine, forming pseudo-vitamin B12 
(Martens  et  al.  2002).  The  different  compounds  in  vitamin  B12 structure can be 
defined as follows (Kumar et al. 2010):  
^ Cobalamin: the complete vitamin B12  
^ Corrinoids represent the sum of cobalamin and analogues.  
^ Vitamin B12 analogues include cobyrinic acid hexaamide, cobinamide and 
cobamide.   
^ Cobyrinic acid hexaamide (cobyric acid, factor V1a): cobalamin molecule without 
the nucleotide loop and D-1-amino-propanol-2 linkage. 
^ Cobinamide: it is the cobyric acid with D-1-amino-propanol-2 linkage. 
^ Cobamide: cobalamin molecule without the DMBI 
^ Pseudo-vitamin B12: when DMBI is replaced by adenine.  
In biological system, the upper ligand is either an adenosyl group (5’-
deoxyadenosylcobalamin) or a methyl group, giving adenosylcobalamin (AdoCbl, 
coenzyme B12) or methylcobalamin (MeCbl), which supply 10-25% and 75-90%, 
respectively, of the body pool of circulating cobalamin (Wheatley 2006). The upper 
ligand can also be substituted by hydroxyl ion, water molecule or cyanide group, 
forming hydroxycobalamin, aquocobalamin and cyanocobalamin (CNCbl), 
respectively. MeCbl and AdoCbl are sensitive to light exposure, resulting 
photochemical degradation to hydroxocobalamin and aquocobalamin at room 
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temperature in aqueous solution (Kerwar et al. 1971). Hence, pharmaceutical 
industry produces vitamin B12 in  the  form  of  CNCbl  that  is  more  stable  due  to  the  
presence of cyanide.     
 
Figure  1.  The  structure  of  vitamin  B12 and some of its derivatives. (Martens et al. 2002; 
Warren et al. 2002). 
2.3 Vitamin B12 in Foods 
As the synthesis of cobalamin exists solely in some bacteria and archaea, the vitamin 
is therefore found only in foods fermented or contaminated by such bacteria. Other 
vitamin B12-containing foods are products derived from the tissues of animals which 
have been fed by vitamin B12-containing feed or which have obtained it from vitamin 
B12-producing bacteria of their commensal microflora (Burgess et al. 2009). The 
vitamin B12-producing bacteria live in the digestive tracts of ruminants and 
synthesize the vitamin as long cobalt source is available. The vitamin is then 
accumulated in the liver of those animals. Certain insects such as termites also 
contain vitamin B12 provided by the gut bacteria (Wakayama et al. 1984). On the 
contrary, the microflora in humans’ gastrointestinal tracts is not sufficient to provide 
vitamin  B12. Hence, humans acquire the vitamin from their diet, mostly by 
consuming animal-derived products such as meat, eggs and dairy products, or taking 
vitamin B12 supplements.  
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Table 1 lists vitamin B12 content  in  some  variety  of  foods.  Meat  of  ruminants  
contains higher vitamin B12 content than poultry. Seafood, especially oysters, clams, 
fish roe and octopus provide substantial amount of vitamin B12.  Vitamin  B12 is 
generally absent in plant-derived foods, unless they are fermented, contaminated or 
fortified. Some good vegetarian sources of vitamin B12 are tempe, seaweeds and 
Chlorella extracts. Tempe, fermented soybean by Rhizopus spp. moulds, contains 
vitamin B12 due to contaminating bacteria such as Citrobacter freundii and Klebsiella 
pneumoniae (Keuth and Bisping 1994; Astuti et al. 2000). The content of vitamin B12 
in tempe varies depending on the conditions of fermentation and the type of 
contaminating bacteria. Seaweeds and other edible algae are reported to contain 
sufficient amount of vitamin B12. However, the activity of vitamin B12 in edible algae 
for humans is still in debate. Research carried out by Watanabe et al. (1999) showed 
that Spirulina tablets contains mostly pseudo-vitamin B12 (7-adenyl cyanocobamide), 
a corrinoid inactive for humans. Although others indicated that Chlorella and laver 
can provide adequate amounts of active vitamin B12 (Rauma et al. 1995; Takenaka et 
al. 2001; Kiittaka-Katsura et al. 2002).       
Table 1. Vitamin B12 content of foods (Liem et al. 1977; Kiittaka-Katsura et al. 2002; Stabler 
and Allen 2004; Kwak et al. 2010).               
Foods 
B12 
(µg/100g) 
Foods 
B12 
(µg/100g) 
Beef liver 83.10a Egg 1.29a 
Beef (ground) 2.56a Clams 96.60a 
Lamb 3.03a Oysters 18.70a 
Goat 1.19a Herring 9.62a 
Pork 0.75a Tuna (canned) 2.99a 
Rabbit 8.30a Fish roe 10.00a 
Turkey 0.37a Octopus 36.00a 
Chicken 0.22a Anchovy 17.12a 
Duck 0.30a Tempe 0.18-6.30a,c 
Cow milk (1%) 0.44a Fish sauce1 1.90c 
Cow milk (whole) 0.20-0.79a 
Laver, dried, seasoned and 
toasted (Nori) 
55.3-71.3b,c 
Cow milk (evaporated) 0.25a Sea lettuce, raw 84.7a,c 
Cheese (cheddar) 2.93a Chlorella tablets 200b,c 
a Vitamin B12 content in µg/100g fresh weight 
b Vitamin B12 content in µg/100g dry weight 
cReported vitamin B12 content probably includes analogues  
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2.4 Physiological Functions of Vitamin B12 
2.4.1 Metabolic Processes in Humans 
In mammalian cells, vitamin B12 is essential to assist two enzymatic activities in 
protein metabolism: methionine synthase and (R)-methyl-malonyl-CoA mutase 
(Figure 2). After absorption, instrinsic factor, haptocorrin (R-protein or 
transcobalamin I) and transcobalamin II (Nielsen et al. 2012) as carrier proteins bind 
vitamin B12 and transport it to the two enzymes. Methionine synthase or 
homocysteine methyltransferase (in the cytosol) requires vitamin B12 in  the  form  
MeCbl to methylate homocysteine to form methionine using 5-
methyltetrahydrofolate as a methyl donor. When vitamin B12 is deficient, 
accumulation of 5-methyltetrahydrofolate occurs, resulting in diminished 
tetrahydrofolate (THF) that is specifically required to convert deoxyuridylate to 
thymidylic acid, one of the four essential precursors in DNA synthesis.    
(R)-methyl-malonyl-CoA mutase (in the mitochondria) requires AdoCbl as coenzyme 
in the catabolism of propionyl-CoA, which is degraded from odd-chain fatty acids, 
certain amino acids (thymine, valine, methionine, threonine and isoleucine) and 
cholesterol. In this process, propionyl-CoA is carboxylated to (S)-methylmalonyl-
CoA and epimerized to form the (R)-isomer. (R)-methyl-malonyl-CoA mutase with 
AdoCbl converts the isomer to succinyl CoA that ends up in the tricarboxylic acid 
(Krebs) cycle (Martens et al. 2002; Truswell 2007). 
Together with pyridoxine (vitamin B6) deficiency and folate deficiency, vitamin B12 
deficiency also leads to elevated homocysteine; a junction metabolite that synthesizes 
intracellular antioxidant glutathione (GSH) (McCaddon et al. 2002; Birch et al. 2009). 
Increased homocysteine level, a condition called hyperhomocysteinemia, is 
associated with endothelial cell dysfunction. It also prevents the antioxidant enzymes 
superoxide dismutase and glutathione peroxidase and triggers endothelial 
proinflammatory signaling pathways. These problems are represented by a major risk 
for heart disease, atherosclerosis, stroke and vascular disease. 
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Figure  2. Cobalamin-dependent enzymatic metabolisms in humans and related metabolic 
pathways (Martens et al. 2002; Manzanares and Hardy 2010). 
2.4.2 Transport and Absorption of Vitamin B12  
Transport and absorption of vitamin B12 from food to the body’s cells are as 
sophisticated as its structure, requiring multistep pathways. Through genetic, 
biochemical and clinical studies on patients with inborn errors of cobalamin 
metabolism, more than 15 gene products (some are listed in Table 2) are recently 
acknowledged to take part in these pathways. The uptake and transport of vitamin B12 
(Figure 3) begin with three homologous carrier proteins in extracellular fluids: 
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haptocorrin, intrinsic factor, and transcobalamin. Each of these proteins is able to 
bind a single vitamin B12 molecule. In the upper gastrointestinal tract, food-bound 
cobalamin is released by peptic activity. Subsequently, haptocorrin that presents in 
saliva, breastmilk and gastric fluids, binds the released vitamin B12 and transport it to 
the small intestines (Quadros 2009). Haptocorrin is thought to protect vitamin B12 
from hydrolysis due to the acidic condition in the stomach. In the duodenum, 
haptocorrin is degraded by pancreatic enzymes and vitamin B12 is bound by instrinsic 
factor secreted by parietal cells of the stomach. In the terminal ileum, intrinsic-factor-
bound vitamin B12 is  bound  on  the  apical  surface  of  ileal  epithelial  cells  through  
endocytosis by cubam (Fyfe et al. 2004); a receptor complex consisting of cubilin and 
amnionless (AMN; a transmembrane, endocytic protein). Inside the enterocyte, 
intrinsic factor is degraded in the lysosome by proteases. Assisted by protein LMBD1, 
the freed vitamin B12 then passes the lysosomal membrane to enter the cytoplasm.  
 
Figure 3. Uptake and transport pathways of vitamin B12 in humans (Nielsen et al. 2012). 
The exact metabolism of vitamin B12 from lysosomal exit until its usage as a 
coenzyme and cofactor is however still slightly known. Based on the current 
knowledge, Figure 4 illustrates the pathways of vitamin B12 cellular uptake and exit. 
In the cytoplasm, vitamin B12 is bound by the cobalamin C protein then passed on to 
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the  cobalamin  D  protein  that  is  suggested  to  carry  vitamin  B12 to apo-methionine 
synthase in the cytosol and to apomethylmalonyl-CoA mutase in the mitochondrion 
(Nielsen et al. 2012). Inside the mitochondrion, cobalamin B protein modifies the 
vitamin B12 fraction to generate AdoCbl, which is later used by (R)-methyl-malonyl-
CoA mutase. The function of the cobalamin A protein is suggested to ensure AdoCbl 
remains in adenosylated state. In the cytosol, the cobalamin E protein is thought to 
generate the rest of vitamin B12 to MeCbl that is used by methionine synthase (Froese 
and Gravel 2010). 
Besides assisting two enzymatic activities, vitamin B12 can exit the cell to enter 
extracellular fluid or bloodstream. The remaining B12 enters  plasma  from  the  
basolateral membranes passing through the ATP-binding cassette (ABC) transporter, 
MRP1  (Beedholm-Ebsen  et  al.  2010).  In  the  bloodstream,  vitamin  B12 is bound to 
transcobalamin, which delivers vitamin B12 to  cells  of  peripheral  tissues.  The  
transcobalamin-bound-B12 is then taken up by cells in the liver and other tissues with 
the  help  of  an  endocytic  receptor,  CD320 protein.  Through renal  filtration,  some of  
the transcobalamin-bound-B12 is  also  reabsorbed  in  the  kidney  mediated  by  the  
receptor megalin (Figure 3), a protein belongs to LDL receptor family located on the 
apical membrane of proximal tubule cells (Birn et al. 2002).       
 
Figure 4. Pathways of vitamin B12 cellular uptake and exit (Nielsen et al. 2012). 
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Table 2. Gene products involved in vitamin B12 transport and absorption from food to cells 
(Banerjee et al. 2009; Froese and Gravel 2010; Nielsen et al. 2012).  
Gene product Location of function Function in vitamin B12 
trafficking 
Haptocorrin Body fluids To bind vitamin B12 
Intrinsic factor Small intestine To bind vitamin B12 
Transcobalamin Blood To bind vitamin B12 
Cubilin (CUBN) Apical surface of the brush 
border epithelial cells in the 
terminal ileum 
The intrinsic factor-B12-
binding subunit of cubam 
Amnionless (AMN) Apical surface of the brush 
border epithelial cells in the 
terminal ileum 
The transmembrane cubam 
subunit that accounts for 
internalization of vitamin B12 
Cobalamin A protein 
(MMAA) 
Mitochondrion To ensure that the cofactor 
form bound by 
methylmalonyl-CoAmutase 
is adenosylcobalamin 
Cobalamin B protein 
(MMAB) 
Mitochondrion To catalyze adenosylation of 
vitamin B12 
Cobalamin C protein 
(MMACHC) 
Cytosol To catalyze decyanation of 
cyanocobalamin and 
dealkylation of 
alkylcobalamins 
Cobalamin D protein 
(MMADHC) 
Cytosol To bind intracellular vitamin 
B12 and direct it to the 
mitochondrial or cytosolic 
pathway 
Cobalamin E protein 
(MTRR) 
Cytosol To catalyze vitamin B12 
methylation  
Cobalamin F protein 
(LMBD1) 
Lysosomal membrane To transport vitamin B12 
from the lysosome to the 
cytosol 
Methionine 
synthase/cobalamin G 
protein 
Cytosol To catalyze methylation of 
homocyteine to form 
methionine 
(R)-methyl-malonyl-CoA 
mutase (MUT) 
Mitochondrion To catalyze the conversion 
of methylmalonyl-CoA to 
succinyl-CoA 
CD320 Plasma membrane To bind transcobalamin-B12 
Multidrug resistance protein 
1 (MRP1/ABCC1) 
Basolateral membranes Molecular gateway for 
vitamin B12 cellular export.   
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2.5 Deficiency of Vitamin B12 
Vitamin B12 deficiency and depletion commonly occur worldwide, particularly 
among vegetarians, vegans and the elderly (Matthews 1995; Stover 2010). This 
prevalence is higher in developing nations and poorer populations in which people 
have a low intake of animal products. The deficiency is usually detected by low 
serum vitamin B12 concentration, measured by microbiological or radio assay. A 
patient is diagnosed with vitamin B12 deficiency when serum B12 is <148 pmol/L. 
While marginal depletion is defined with serum B12 is 148-221 pmol/L (Allen 2009). 
Other indicators of vitamin B12 deficiency are elevated serum methylmalonic acid 
(MMA>210 nmol/L) and homocysteine. Raised serum MMA provides more reliable 
vitamin B12 deficiency status than homocysteine as serum MMA is not increased by 
folate deficiency (Truswell 2007).  
2.5.1 The Nutritional Requirements 
To achieve absorption of 1 µg/d, the Institute of Medicine (1998) set Recommended 
Daily  Allowance  (RDA)  of  vitamin  B12 at  2.4  µg/d,  assumed  that  50%  of  dietary  
vitamin  B12 is absorbed by healthy adults (Heyssel et al. 1966; Russell et al. 2001). 
The required intake is higher for pregnant and lactating women; 2.6 µg/day and 2.8 
µg/day, respectively. Consumption of vitamin B12 fortified  foods  or  vitamin  B12-
containing supplements is highly recommended for those older than 50 years as 10-
30% of older adults may be unable to absorb naturally occurring vitamin B12. 
Vitamin B12 has a low risk of toxicity, even taken in high doses and the upper limits 
for intake have not been defined (Flynn et al. 2003). Table 3 lists RDA of vitamin B12 
based on age groups. 
Table 3. Recommended dietary allowance for different age groups.  
Age Food and Nutrition Board1(µg/d) FAO/WHO2 (µg/d) 
0 to 6 months 0.4 0.4 
7 to 12 months 0.8 0.7 
1 to 3 years 0.9 0.9 
4 to 8 years 1.2 1.2 (4 to 6 years) 
  1.8 (7 to 9 years) 
9 to 13 years 1.8 2.4 
14 to 18 years 2.4 2.4 
>19 years 2.4 2.4 
Pregnant women 2.6 2.6 
Lactating women 2.8 2.8 
1 Food and Nutrition Board (2000) 
2 FAO/WHO (2004) 
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2.5.2 Deficiency Diseases 
Since the liver is able to store sufficient amount of vitamin B12 for several years, 
vitamin B12 deficiency is developed gradually. Thus, biochemical and subclinical 
deficiency, i.e. low B12 serum  and/or  high  MMA  appear  first.  Two  major  clinical  
syndromes: megaloblastic anaemia and/or neuropathy occur in the severe deficiency 
(serum B12<120-150 pmol/L). In megaloblastic anaemia, immature nuclei, enlarged 
red cells (macrocytosis) and hypersegmentation in granulocytes are found in 
peripheral blood and bone marrow (Stabler 2013; Truswell 2007). The neuropathy 
symptoms include spinal cord, cranial or peripheral nerve, or cerebral demyelination, 
which may lead to muscle weakness, spasticity, dementia, psychoses, ataxia, and 
Alzheimer’s disease. Infants of vitamin B12-deficient or vegan mothers may be born 
with the deficiency or it develops if they are exclusively breastfed. Symptoms in 
infants occur between 4-6 months of age and these include movement disorders 
(tremors, twitching and writhing), abnormal reflexes, feeding difficulties, 
hyperirritability, lethargy, developmental regression and failure of brain growth that 
can progress to coma (Honzik et al. 2010). Early diagnosis and immediate vitamin 
B12 replacement can reverse the symptoms and prevent permanent disabilities.  
2.5.3 Causes of Vitamin B12 Deficiency  
In younger adults and developing countries, inadequate dietary intake is likely the 
main  cause  of  vitamin  B12 deficiency  while  in  older  adults,  malabsorption  of  the  
vitamin  from  the  food  is  the  common  cause  of  deficiency.  Table  4  lists  causes  of  
vitamin B12 deficiency and the recommended treatments.  
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Table 4. Causes and treatments of vitamin B12 deficiency (Yousef and Andrés 2008; Nielsen 
et al. 2012; Stabler 2013). 
Cause Treatment 
Severe malabsorption 
Pernicious anemia (autoimmune 
gastritis) 
1000 µg of intramuscular 
cyanocobalamin, injected daily or every 
other day for a week, then weekly 4-8 
week followed by monthly injection for 
life. Another option is oral treatment of 
1000-2000 µg cyanocobalamin, taken 
daily for life. 
Gastric bypass surgery 
Total/partial gastrectomy 
Inflammatory bowel disease, tropical 
sprue 
Chrohn’s disease  
Coeliac disease 
Parasitic infection e.g. fish tapeworm 
Diphyllobothrium latum and protozoa 
Giardia lamblia 
Treating the infection, followed by 
cyanocobalamin injection.  
Mild malabsorption 
Mild atrophic gastritis, related or 
unrelated to Helicobacter pylori 
infection 
Oral treatment of 500-1000 µg daily or 
intramuscular cyanocobalamin of 1000 
µg daily or every other day for a week, 
then weekly 4-8 week followed by 
monthly injection for life.   
Protein-bound vitamin B12 
malabsortion 
Prolonged use of antacids 
Dietary deficiency 
Breastfed infants by vitamin B12-
deficient mothers 
Daily cyanocobalamin injection of 250-
1000 µg, then weekly until full recovery. 
Treatment of mother to enrich breast 
milk; daily supplementation of 1-2 µg of 
vitamin B12 or vitamin B12-enriched 
food. 
Practicing vegetarian or vegan diet, or 
diet low in meat and dairy products 
Take supplements containing >2 µg of 
vitamin B12 or B12-fortified foods.  
2.6 Vitamin B12 Biosynthesis in Microorganisms 
Biosynthesis of vitamin B12 exists only in microorganisms; some bacteria and 
archaea. Although animals (including humans) and protists require cobalamin, they 
are not able to synthesize it, while plant and fungi ostensibly neither require nor 
synthesize it. There are two biosynthesis pathways for vitamin B12 (Blanche et al. 
1993; Burgess et al. 2009): (1) oxygen-dependent pathway (aerobic) that is found in 
Pseudomonas denitrificans and (2) oxygen-independent pathway (anaerobic), which 
has been shown in Salmonella typhimurium, Bacillus megaterium and 
Propionibacterium freudenreichii.  
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The biosynthesis of vitamin B12 begins with the formation of 5-aminolevulenic acid 
(ALA),  the  first  general  precursor  of  all  known  tetrapyrroles  (Raux  et  al.  2000;  
Martens et al. 2002; Scott and Roessner, 2002). ALA is synthesized by two 
biosynthetic routes, C5-Way and C4-Way (Shemin-Way) (Figure 5). Plants, archaea 
and most bacteria synthesize ALA via C5-Way, in which the C-5 skeleton of 
glutamyl-tRNA is reduced to glutamate-1-semialdehyde (GSA) by NADPH-
dependent glutamyl-tRNA reductase (GluTR). Later, pyridoxal 5’-phosphate (PLP)-
dependent glutamate-1-semialdehyde-2, 1-aminomutase (GSAM) converts GSA into 
ALA by a transamination reaction (Layer et al. 2010). While mammals, fungi and Į-
group of proteobacteria produce ALA via Shemin-Way (named  after  one  of  the  
two  discoverers), in which glycine and succinyl-CoA are condensated and then 
catalyzed by 5-aminolevulinic acid synthase (ALAS).    
 
Figure  5. Formation of 5-aminolevulinic acid (ALA) via C5-Way and Shemin-Way (Layer 
et al. 2010). 
Eight molecules of ALA then undergo three consecutive enzymatic steps to form 
uroporphyrinogen III (Figure 6a). Firstly, two molecules of ALA are condensed with 
the help of porphobilinogen synthase (PBGS) to produce the pyrrole derivative, 
porphobilinogen. Next, porphobilinogen deaminase (PBGD) connects four molecules 
of porphobilinogen to form preuroporphyrinogen (1-hydroxymethylbilane), which is 
then converted to uroporphyrinogen III (the first cyclic tetrapyrrole) under inversion 
of the D ring by uroporphyrinogen III synthase (UROS). If decarboxylated, 
uroporphyrinogen III is the intermediate in chlorophyll and hemes biosynthesis. In 
cobalamin biosynthesis, uroporphyrinogen III is instead methylated at C-2 and C-7 to 
form precorrin-2, a dimethylated dipyrrocorphin that is also found in siroheme, heme 
d1 and coenzyme F430 synthesis (Martens et al. 2002). The methylation is catalyzed 
by S-adenosyl-L-methionine uroporphyrinogen III methyltransferase (SUMT). 
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Furthermore, cobalamin and siroheme biosynthesis are closely integrated (Figure 6b) 
as two intermediates in siroheme biosynthesis; precorrin-2 and sirohydrochlorin 
(factor II) distinguish aerobic and anaerobic pathways of cobalamin biosynthesis. The 
formation of adenosylcobalamin from uroporphyrinogen III in both pathways 
involves these seven following reactions: 
^ The attachment of eight methyl groups derived from S-adenosyl-L-methionine 
(SAM). 
^ The insertion of cobalt. 
^ Ring contraction with removal of the methylated C-20 resulting as either acetic 
acid or acetaldehyde.  
^ Decarboxylation of the acetic acid side chain on ring C. 
^ Amidation of six of the eight acidic side chains. 
^ The formation of upper axial ligand. 
^ Attachment of D-1-amino-propanol-2 to the propionate side chain on ring D.  
^ Biosynthesis and attachment of the lower nucleotide loop.  
 
 
              
Figure 6. a. Conversion of ALA into uroporphyrinogen III by three consecutive enzymatic steps. b. Integration of siroheme and cobalamin biosynthesis. Modified from 
Martens et al. (2002) and Layer et al. (2010). 
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The major differences between the two pathways are the timing of cobalt insertion 
and the method used to promote the ring-contraction. In the anaerobic pathway, 
cobalt insertion occurs at early step (Figure 7a); in which sirohydrochlorin is chelated 
to form cobalt-precorrin-2, a reaction that is catalyzed by a number of 
cobaltochelatases: CbiK, CbiXL,  or  CbiXS (Raux et al. 1997; Brindley et al. 2003; 
Leech et al. 2003). In the aerobic pathway, the cobalt insertion occurs after nine 
further reactions, where hydrogenobyrinic acid a,c-diamide is chelated to form 
Cob(II)yrinic acid a,c-diamide mediated by CobN, CobS and CobT (Debussche et al. 
1992). In the aerobic pathway, the cobalt insertion requires ATP, while no high-
energy equivalents required in the anaerobic pathway. To promote the ring-
contraction process (Figure 7b), under aerobic conditions, the C-20 atom of 
precorrin-3A is firstly oxidized by O2 to form precorrin-3B, a process catalyzed by a 
Fe4S4 cluster containing protein (CobG) resulting the release of C-20 as acetic acid. 
In the presence of SAM, Cob J then mediates the ring contraction and methylates the 
C-17 in precorrin-3B to form precorrin-4. Under anaerobic conditions, the C-20 atom 
in cobalt-precorrin-2 is methylated by CbiL resulting cobalt-factor III or cobal-
precorrin-3, which is later mediated by CbiH to undergo the ring contraction. The C-
20 atom in anaerobic pathway is then released as acetaldehyde.                 
 
Figure 7. Simplified diagram of cobalt insertion (a.) and ring contraction (b.) in the aerobic 
and anerobic pathways, modified from Moore and Warren (2012).   
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The differences are shown at the genetic level by the presence or absence of more 
than 30 genes involved in the biosynthesis (Table 5). The genes encoding proteins are 
isolated and sequenced from Pseudomonas denitrificans (Blanche et al. 1995), 
Salmonella typhimurium (Roth et al. 1993), Bacillus megaterium (Raux et al. 1998) 
and Propionibacterium freudenreichii subsp. shermanii (Roessner et al. 2002). The 
genes are distinguished to prefix cob (cobalamin biosynthesis) for the aerobic 
pathway and prefix cbi (cobinamide biosynthesis) for the anaerobic pathway. Despite 
these differences, at the level of adenosylcobyric acid, both pathways undergo 
identical steps involving conversion of Ado-cobyric acid to Ado-cobalamin by the 
addition of aminopropanol and DMBI via adenosylcobinamide.      
Table  5. The genes listed for the oxygen-dependent pathway are from P. denitrificans. The 
genes listed for the oxygen-independent pathway are from S. enterica.  Adapted  from  
Roessner et al. (2002), Roessner and Scott (2006) and Layer et al. (2010). 
Oxygen Dependent/Late 
Cobalt Insertion Pathway 
Gene Oxygen Independent/Early 
Cobalt Insertion Pathway 
Gene 
Aminolevulinic acid (ALA) 
  condensation of 2 ALA 
 
hemB 
Aminolevulinic acid (ALA) 
  condensation of 2 ALA 
 
hemB 
Porphobilinogen 
  tetrapyrrole formation 
 
hemC 
Porphobilinogen 
  tetrapyrrole formation 
 
hemC 
Hydroxymethylbilane 
  cyclisation and ring D 
conversion 
 
hemD 
Hydroxymethylbilane 
  cyclisation and ring D 
conversion 
 
hemD 
Uroporphyrinogen III 
  methylation at C-2 and C-7 
 
cobA 
Uroporphyrinogen III 
  methylation at C-2 and C-7 
 
cysG 
Precorrin-2 
  methylation at C-20 
 
cobI 
Precorrin-2 
Sirohydrochlorin 
  cobalt insertion 
 
 
cysG, 
cbiK 
Precorrin-3 
  C-20 hydroxylation 
  J-lactone formation 
 
cobG 
Cobalt-precorrin-2 
  methylation at C-20 
 
cbiL 
Precorrin-3-hydroxylactone 
  C-17 methylation 
  ring contraction 
 
cobJ 
Cobalt-precorrin-3 
  C-17 methylation 
  ring contraction 
  J-lactone formation 
 
cbiH 
Precorrin-4 
  C-11 methylation 
 
cobM 
Cobalt-precorrin-4 
  C-11 methylation 
 
cbiF 
Precorrin-5 
  C-1 methylation 
  acetic acid extrusion 
 
cobF 
Cobalt-precorrin-5A 
  opening of lactone ring 
  acetaldehyde extrusion 
Cobalt-precorrin-5B 
  C-1 methylation 
 
cbiG  
 
 
cbiD 
Precorrin-6 
  C-18/C-19 reduction 
 
cobK 
Cobalt-precorrin-6 
  C-18/C-19 reduction 
 
cbiJ 
Dihydroprecorrin-6 
  C-5, C-15 methylation 
  decarboxylation 
 
cobL 
cobL 
Cobalt-dihydroprecorrin-6 
  C-5, C-15 methylation 
  decarboxylation 
 
cbiE 
cbiT 
26 
 
Precorrin-8 
  methyl rearrangement 
 
cobH 
Cobalt-precorrin-8 
  methyl rearrangement 
 
cbiC 
Hydrogenobyrinic acid 
  a,c-amidation 
 
cobB 
Cobyrinic acid 
  a,c-amidation 
 
cbiA 
Hydrogenobyrinic acid a,c-
diamide 
  cobalt insertion 
 
 
cobN, 
cobS, 
cobT 
Cob(II)yrinic acid a,c-diamide 
  Cobalt reduction 
 
 
fldA 
Cob(II)yrinic acid a,c-diamide 
  Cobalt reduction 
 
cobR? 
  
Cob(I)yrinic acid a,c-diamide 
  adenosylation 
 
cobO 
Cob(I)yrinic acid a,c-diamide 
  adenosylation 
 
cobA 
Ado-cob(I)yrinic acid a,c-
diamide 
  b,c,e,g-amidation 
 
 
cobQ 
Ado-cob(I)yrinic acid a,c-
diamide 
  b,c,e,g-amidation 
 
 
cbiP 
Ado-cobyric acid 
  aminopropanol attachment 
 
cobC, 
cobD,
? 
Ado-cobyric acid 
  aminopropanol attachment 
 
cbiB,? 
Ado-cobinamide 
  phosphorylation 
  GMP addition 
 
cobP 
cobP 
Ado-cobinamide 
  phosphorylation 
  GMP addition 
 
cobU 
cobU 
Ado-GDP-cobinamide 
  a-ribazole addition 
 
cobV 
Ado-GDP-cobinamide 
  a-ribazole addition 
 
cobS 
Ado-cobalamin 5’-phosphate 
  dephosphorylation 
 
? 
Ado-cobalamin 5’-phosphate 
  dephosphorylation 
 
cobC 
Ado-cobalamin  Ado-cobalamin  
2.7 Biosynthesis of 5,6-dimethylbenzimidazole (DMBI)  
Although the attachment of the lower nucleotide loop of cobalamin has been 
elucidated (Maggio-Hall and Escalante-Semerena 1999), the biosynthesis of DMBI, 
the  lower  ligand  of  vitamin  B12 has  remained  an  enigma.  Previous  studies  on  the  
biosynthesis of DMBI have been performed in the obligate anaerobe, Eubacterium 
limosum,  in  which  DMBI was  synthesized  from formate,  glycine,  glutamine,  SAM, 
and erythrose-4-phosphate (Höllriegl et al. 1982; Munder et al. 1992). It was also 
found that E. limosum efficiently transformed 5-hydroxybenzimidazole and 5-
hydroxy-6-methylbenzimidazole to DMBI (Renz et al. 1993; Schulze et al. 1998). 
However, other studies revealed that some organisms required molecular oxygen to 
synthesize DMBI. P. freudenreichii (Renz 1970; Renz and Weyhenmeyer 1972; 
Hoerig and Renz 1977) and Salmonella enterica (Keck et al. 1998) transform 
riboflavin to DMBI through riboflavin 5’-phosphate/flavin mononucleotide (FMN) 
via an oxygen-dependent reaction (Figure 8a), in which the C-1 carbon of the ribose 
moiety of FMN is transformed into C-2 carbon of DMBI. In anaerobic conditions, S. 
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enterica does not synthesize DMBI; instead it synthesizes adenyl and 2-
methyladenylcobamide (Keck and Renz 2000). Despite the understanding that the 
transformation of riboflavin to DMBI involves molecular cannibalization, the genes 
or enzymes involved in either the aerobic or anaerobic biosynthesis of DMBI 
remained unknown until the recent discovery of bluB, a gene identified as causing 
vitamin  B12 deficiency in the phototropic purple nonsulfur bacterium, Rhodobacter 
capsulatus.   
BluB gene was first found in a cluster of sequenced R. capsulatus genes (Pollich and 
Klug 1995). It was suggested that five (bluFEDCB) out of eight genes isolated were 
involved in the late steps of cobalamin biosynthesis due to the strong homology with 
22 cob genes  of  P. denitrificans. The correction assay also indicated that bluB was 
involved in the conversion of cobinamide to cobalamin. The blu prefix is given due 
to the fact that bluE and bluB genes are required to make an aerobic culture blush 
after the reduction of the partial O2 pressure (pO2). The evidence that bluB was 
involved in DMBI synthesis first appeared in a patent (Blanche et al. 2000) using a 
mutant of R. capsulatus, which claimed that overproduction of bluB led to increased 
levels of DMBI. Later, the role of bluB gene in DMBI synthesis was also confirmed 
by Campbell et al. (2006) using mutants of Sinorhizobium meliloti.  
According to the protein sequence, bluB has §16% similarity to several  enzymes of 
NADH/FMN-dependent nitroreductase/oxidoreductase family. Based on this 
sequence, Taga et al. (2007) described the structure of bluB (Figure 8c) and proposed 
that in the presence of molecular oxygen, bluB is able to catalyze the cannibalism of 
FMN to DMBI with the release of D-erythrose 4-phosphate. An alternative 
mechanism  of  FMN  transformation  to  DMBI  was  suggested  by  Ealick  and  Begley  
(2007) based on the simplicity of the bluB active site, in which a series of reactions 
with water dismantles the flavin after it has reacted with molecular oxygen (Figure 
8b). First, FMN reacts with oxygen to yield flavin hydroperoxide followed by a ring 
expansion with loss of a water molecule to produce intermediate A. This disintegrates 
further via four hydrolysis reactions, in which it is attacked by water molecules 
resulting diaminobenzene. Lastly, diaminobenzene undergoes two oxidation reactions 
forming DMBI.  
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Figure 8. a. Biosynthesis of DMBI from flavin mononucleotide (FMN) in oxygen dependent 
reaction. (Warren 2006). b. Proposed mechanism that bluB catalyzes a reaction in which 
FMN  transforms  into  DMBI  (Ealick  and  Begley  2007).  c. Structure of bluB,  where  the  
monomers are colored green helices/orange sheets and blue helices/purple sheets. The orange 
balls are oxygen-trapped structure of the enzyme (Layer et al. 2010). 
2.8 Vitamin B12 Production 
Chemical synthesis of vitamin B12 was successfully achieved by Woodward (1973) 
and Eschenmoser (1974). However, the chemical process requires 70 complex steps 
that make any industrial production by chemical methods technically too complicated 
and expensive. Thus, commercial vitamin B12 has been produced intra- or 
extracellularly on an industrial scale using the batch or fed-batch process of microbial 
fermentation (Yongsmith et al 1982), followed by extraction and purification using 
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organic solvents. Nowadays, the industrial production of vitamin B12 utilizes selected 
and genetically modified microorganisms to provide more economical process and 
enhance the quality of end products. The common methods to increase the yields of 
vitamin B12 are random mutagenesis and genetic engineering. In random mutagenesis, 
the microorganisms are usually treated with mutagenic agents such as UV light, 
ethyleneimine, nitrosomethyluretane or N-methyl-N’-nitro-N-nitrosoguanidine. The 
strains are then selected according to the practical advantages such as genetic stability, 
productivity, reasonable growth rates and resistance to high concentrations of toxic 
precursors present in the medium (Martens et al. 2002).  
There are currently three bacteria used for commercial production of vitamin B12: 
Bacillus megaterium, Pseudomonas denitrificans, and Propionibacterium (Battersby 
1994; Roth et al. 1996; Hunik 1999), the latter two are more commonly used today 
due to the high yields. Since the strains from genus Propionibacterium are food-
grade and produce no exotoxins or endotoxins, they are preferably used and granted 
GRAS (generally recognized as safe) by the United States Food and Drug 
Administration. Thus, vitamin B12 can be directly produced in the food or added to 
the food, without any further complex processing. Nonetheless, one of the biggest 
vitamin  B12-producing companies from France, Rhône-Poulenc, now known as 
Sanofi-Aventis, uses mainly P. denitrificans to produce the vitamin. Under Rhône-
Poulenc, Blanche et al. (1995) created a highly effective vitamin B12-producing strain 
from genetically engineered P. denitrificans. Although no official information is 
known on the productivity, the strain is believed to have productivity up to 300 mg/L. 
An article made by Yang et al. (2003) reported the use of methanogens in vitamin B12 
production that have several advantages over conventional vitamin B12 producers 
such as (1) ten times higher vitamin B12 concentration in the broth than in 
Propionibacterium (Zhang et al. 2001); (2) methane does not inhibit the growth of 
methanogens and could provide a high cell density culture system; and (3) methanol, 
CO2 and acetic acid used as substrates are inexpensive, relatively stable and 
renewable. More vitamin B12 producing species are observed from the following 
genera: Aerobacter, Agrobacterium, Alcaligenes, Azotobacter, Bacillus, Clostridium, 
Corynebacterium, Flavobacterium, Micromonospora, Mycobacterium, Norcardia, 
Propionibacterium, Protaminobacter, Proteus, Rhizobium, Salmonella, Serratia, 
Streptomyces, Streptococcus and Xanthomonas (Perlman 1959). Table 6 enlists the 
most active species of microorganisms utilized in vitamin B12 production.  
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Table  6. Species of microbial producers recommended for vitamin B12 production. 
(Bykhovsky et al. 1998) 
Species Substrate Condition of fermentation Yield 
(mg/L) 
Propionibacterium freudenreichii  Glucose Anaerobiosis, DMBI 206.0 
Rhodopseudomonas protamicus Glucose DMBI 135.0 
Propionibacterium shermanii Glucose DMBI 60.0 
Pseudomonas denitrificans Sucrose Aerobiosis, betaine 60.0 
Nocardia rugosa Glucose Aerobiosis 18.0 
Rhizobium cobalaminogenum Sucrose Aerobiosis 16.5 
Micromonospora sp.  Glucose DMBI 11.5 
Streptomyces olivaceus Glucose DMBI 6.0 
Nocardia gardneri Hexadecane  Aerobiosis 4.5 
Butyribacterium 
methylotrophicum 
Methanol  Anaerobiosis  3.6 
Pseudomonas sp.  Methanol  DMBI 3.2 
Arthrobacter hyalinus  Isopropanol DMBI 1.1 
2.8.1 Fermentative Production of Vitamin B12  
Previous descriptions about fermentative production of vitamin B12 by 
Propionibacterium have mainly focused on growing the bacteria to high cell densities 
by  varying  the  nutrient  composition  of  the  growth  medium  such  as  amino  acid  or  
mineral composition, which apparently only affected vitamin B12 production when 
the growth yield of the Propionibacterium was improved (Hugenholtz and Smid 
2002). It was later found that both the addition of the precursor DMBI and aerobic 
incubation in the latter phase of fermentation increased vitamin B12 yields. Based on 
these two experimental findings, Hunik (1999) patented a semi-continuous, two-stage, 
large-scale production process that resulted in a 3-fold increase of vitamin B12 
production.        
Albeit Propionibacterium can  grow  under  aerobic  conditions,  the  production  of  
corrinoids (precursors of vitamin B12) is absent when the concentration of dissolved 
oxygen is  above  0.19  mM (6  mg O2/L). The lower the O2 concentration, the higher 
the corrinoid production with a maximum production under non-aerated conditions 
(Quesada-Chanto et al. 1998). In contrary, the biosynthesis of DMBI requires oxygen. 
Thus, the production using Propionibacterium strains is divided into two stages. In 
the first stage, the bacteria are grown anaerobically for 72-88 hours to produce 
cobamide, a precursor of vitamin B12 missing the DMBI moiety (Martens et al. 2002). 
In the second stage, aeration is applied for another 72-88 hours, allowing the bacteria 
to  undertake  the  aerobic  synthesis  of  the  DMBI  and  to  link  it  to  cobamide.  The  
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fermentation also produces propionic acid, which gives advantage in inhibiting the 
growth of other microorganisms such as lactic acid bacteria and yeasts. However, at 
level 20-40 g/L (Hunik 1999), propionic acid starts to inhibit the growth of 
Propionibacterium. Hence, it is crucial to neutralize the accumulated propionic acid 
to  maintain  the  production  culture  at  pH 7.  Contrary  to  the  fermentation  process  in  
Propionibacterium, vitamin B12 production in P. denitrificans parallels aerobic 
growth with high vitamin B12 production rates if the culture is directly supplemented 
with DMBI and cobalt salts. The culture is aerated for about 48-72 hours at 30°C and 
pH values are maintained at 6-7.   
2.8.2 Optimization and Genetic Engineering in Vitamin B12 Production  
Vitamin B12 production can be optimized by varying the substrates, culture 
inoculations (Wyk et al. 2011), pH value, temperature and aeration (Quesada-Chanto 
et al. 1994). Besides the addition of cobalt and DMBI, further additions of potential 
precursors like glycine, threonine, į-aminolevulinic acid, betaine and choline proved 
to be beneficial (Marwaha et al. 1983). Through cloning and expression of 10 genes 
belonging to the hem, cob and cbi from Rhodobacter sphaeroides and P. 
freudenreichii, Piao et al. (2004) successfully increased the production of vitamin B12 
in P. freudenreichii. The group achieved 2.2-fold vitamin B12 concentration (1.7 
mg/L) by using a recombinant P. freudenreichii clone that harbored an exogenous 
gene, hemA, from Rhodobacter sphaeroides and endogenous hemB and cobA genes. 
The genetic engineering in P. denitrificans involved the amplification of the eight 
genes in the cobF-cobM operon, which resulted a 30% increase. An additional 20% 
enhancement was achieved by increasing cobA and cobE genes (Blanche et al. 1998).  
2.8.3 Recovery of Vitamin B12           
The recovery of vitamin B12 (Figure 9) requires several steps to obtain final product 
with high purity. The biomass is centrifuged to obtain a cell mass concentrate, which 
is later dried. The whole batch can also be concentrated or spray dried. The cell mass 
is heated in aqueous solution at 80-120°C for 10-30 min. at pH 6.5-8.5 to release 
vitamin  B12, which are later converted to cyanocobalamin by the addition of 
potassium cyanide or thiocyanate (Spalla et al. 1989), usually in the presence of 
sodium nitrite and heat. For animal feed additives, the vitamin solution is clarified by 
filtration or treatment with zinc chloride, and then precipitated by the addition of 
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tannic acid or cresol giving 80% of purity. For food and pharmaceutical purposes, 
which require higher purity, after filtration, the solution is extracted with organic 
solvents, such as carbon tetrachloride and later water/butanol. The last step is 
crystallization of vitamin B12 after the addition of phenol and water.  
 
Figure 9. Flowchart of vitamin B12 recovery processes (Survase et al. 2006). 
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2.9 Production of Vitamin B12 in Plants-derived Foods and Spent Media 
Since vegetarians and vegans are the most susceptible groups in vitamin B12 
deficiency, as previously mentioned, they usually consume vitamin B12-fortified 
foods and/or vitamin B12 supplement  to  meet  the  daily  requirement.  However,  with  
the growing awareness of well-being and healthy living, the trends of consuming 
natural and food grade supplements are increasing. In recent vitamin B12 production, 
more researches have been carried out to optimize in situ cereal fermentations 
utilizing particularly lactic acid bacteria (LAB) due to their qualified presumption of 
safety  (QPS)  and  GRAS  status.  Although  P. denitrificans and P. freudenreichii are 
the  most  commonly  used  strains  in  vitamin  B12 production, some LAB have been 
found to  be  vitamin  B12 producers such as Lactobacillus reuteri CRL1098 (a strain 
isolated from sourdough), the first documented vitamin B12-producing LAB (Taranto 
et al. 2003; Santos 2008). Moreover, the complete vitamin B12 biosynthesis gene 
cluster of Lb. reuteri CRL1098 has been encoded, which brings a major advantage in 
metabolic engineering for transferring the ability to produce vitamin B12 to other 
bacteria (Santos et al. 2008). Another LAB found in traditionally fermented 
sourdough, Lactobacillus sanfranciscensis, may open new and attractive ways for 
vitamin B12 production in cereal fermentation. Previously acknowledged of unable to 
synthesize folate, thiamine, riboflavin and vitamin B6, the recently sequenced Lb. 
sanfranciscensis TMW1.1304 revealed one gene (cobyrinic acid a, c-diamide 
synthase, EC 6.3.5.11; LSA_2900630) involved in cobalamin synthesis (Vogel et al. 
2011). Moreover, other studies have been carried out to utilize waste products as the 
substrate in vitamin B12 production. Cheese whey has been successfully shown to be 
used in vitamin B12 production (Bullerman and Berry 1966; Marwaha & Sethi 1984). 
Gardner and Champagne (2005) demonstrated the use of spent media (MRS medium) 
and prefermented vegetable juices obtained from the production pickled vegetables to 
produce P. freudenreichii biomass and vitamin B12. This alternative process may be 
beneficial from economical and environmental standpoints as the fermentation may 
result in three commercial products: biomass, vitamin B12 or organic acids, which can 
be further utilized as starters, supplements or food preservatives, respectively. 
The product that contains vitamin B12 through in situ cereal fermentation yet often 
overlooked is tempe/tempeh. Originally made by Central Javanese people in 1700s, 
tempe initially became popular due to its high protein content (20%), which is 
comparable with chicken (21%), beef (20%) and egg (13%) (Shurtleff and Aoyagi, 
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2001). As a vegetarian food shown to naturally contain vitamin B12, tempe is 
produced by soaking, dehulling and cooking soybeans (or other legumes, seeds and 
cereal grains). The beans are then surface dried and inoculated with spores of 
Rhizopus spp. (R. oligosporus, R. stolonifer, R. arrhizus, and R. oryzae) forming 
compact patties. During the solid substrate fermentation (SSF), Rhizopus strains form 
other water soluble vitamins such as riboflavin, nicotinic acid, nicotinamide and 
vitamin  B6 (Keuth and Bisping 1993). The moulds, however, do not produce 
physiologically active vitamin B12. In traditional tempe production, vitamin B12 is 
formed due to bacterial contamination that occurs during soaking and/or SSF. 
Particularly during soaking, bacterial acidification takes place, which avoids growth 
of spoilage microorganisms and creates optimum growth conditions for Rhizopus spp. 
In modern tempe production in Western countries, bacterial acidification is replaced 
by adding lactic acid to shorten the fermentation time. Moreover, the beans are 
inoculated with pure cultures of Rhizopus, explaining the absence of vitamin B12 
(Liem et al. 1977).  
In a screening for vitamin B12-producing bacteria isolated from Indonesian tempe 
samples, 13 out of 33 isolates were Kl. pneumoniae (Okada 1989). Others bacteria 
were  also  found  such  as  Kl. terrigena, Kl. planticola, Kl. ozeanae, Enterobacter 
cloacae and Escherichia coli. Two strains from Cit. freundii and Kl. pneumoniae 
were found to be the best vitamin B12-producing bacteria in tempe production (Keuth 
and Bisping 1993). However, Cit. freundii and Kl. pneumoniae strains are known to 
possess three known genes for enterotoxin production: the genes for Shiga-like toxin 
SLT  IIA  (Schmidt  et  al.  1993),  for  heat-labile  enterotoxin  LT  Ih  (Yamamoto  and  
Yokota 1983), and for heat-stable enterotoxin ST Ih (Moseley et al. 1983). 
Nevertheless, neither Cit. freundii nor Kl. pneumoniae that was isolated from 
Indonesian tempe, possessed the three mentioned genes, as indicated by PCR (Keuth 
and Bisping 1994). Interestingly, although tempe may contain many members of the 
family Enterobacteriaceae, no reports exist about diarrhea after the consumption of 
tempe. Hence, the use of Cit. freundii and Kl. pneumoniae in tempe fermentation 
should have no negative effect on the consumers. Keuth and Bisping (1994) also 
observed the influence of cobalt and DMBI supplementation in vitamin B12 content. 
Both precursors significantly increased vitamin B12 content in tempe from 73 to 170 
ng/g for Kl. pneumoniae and up to 290 ng/g for Cit. freundii. However, the 
incorporation of the precursors was poor, resulting low yields. In conclusion, the 
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addition  of  cobalt  and  DMBI  is  unnecessary,  as  the  vitamin  B12 concentration 
produced in tempe by either of these two strains would be sufficient to meet the daily 
requirement of an adult.                    
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3 EXPERIMENTAL RESEARCH 
3.1 Objectives 
Plant-based fermented foods that contain naturally synthesized vitamin B12 are still 
limited. In addition, published results on production of vitamin B12 by 
Propionibacteria (one  of  the  highest  vitamin  B12-producing bacteria) in plant-based 
foods do not exist although it has potential applications in enriching plant-based 
foods with vitamin B12. Furthermore, the knowledge on the role of food components 
that can influence the synthesis of vitamin B12 in cereal or other plant-based foods is 
lacking. Thus, the primary aim of the study was to investigate the requirement of 
different  precursors  in  the  biosynthesis  of  vitamin  B12 in optimal media conditions 
and then in cereal matrices using strains of Propionibacterium freudenreichii. The 
study also investigated differences of vitamin B12 production among the strains of P. 
freudenreichii with respect to the added precursors.  
3.2 Materials and Methods 
3.2.1 Propionibacterium Culture Preparation 
Prior to vitamin B12 production, three strains of P. freudenreichii (strain 1, 2 and 3) 
were first inoculated on agar plates and subcultured three times for three to four 
days at 30°C in supplemented whey permeate (SWP) medium. All strains were kept 
as frozen stocks at -80°C in glycerol.  
3.2.2 Chemicals and Growth Matrices 
Agar Plates 
All chemicals were acquired from Merck KgaA (Darmstadt, Germany) unless 
otherwise stated. The agar medium used for inoculation consisted of 15 g of agar 
powder (DifcoTM Granulated Agar, Becton, Dickinson and Company, USA), 10 g of 
yeast extract powder (Lab M Limited, Lancashire, United Kingdom), 5 g of 
tryptone  (Sigma-Aldrich  Chemie,  Steinheim,  Germany)  and  14  mL  of  sodium  
lactate  (60%;  Sigma-Aldrich  Co.,  St.  Louis,  MO,  USA)  in  1  L  of  Milli-Q  water  
(Milli-Q Plus; Millipore S.A., France). The agar plate was prepared as follows: 
tryptone, yeast extracts and sodium lactate 60% were diluted in Milli-Q water with 
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pH adjusted to 7.3 ± 0.2 (5M NaOH). The agar powder was then added in the 
suspension followed by autoclaving (121°C, 15 min).  
Supplemeted Whey Permeate (SWP) 
The SWP medium used in sub-culturing and production of vitamin B12 contained 
final  concentration  of  60  g  of  whey permeate  (demineralised  whey powder;  Valio  
Ltd,  Lapinlahti,  Finland),  0.1  g  of  Tween  80  (Sigma-Aldrich  Co.,  St.  Louis,  MO,  
USA), 10 g of yeast extract, 0.2 g of magnesium sulphate and 0.05 g of manganese 
(II)  sulphate  in  1  L  of  0.1  M  potassium  phosphate  buffer  pH  6.4.  The  SWP  was  
prepared according to Hugenschmidt et al. (2010): 85.7 g/L whey powder with pH 
adjusted to 5.0 (5M HCl) was autoclaved (121°C, 20 min). The suspension was 
cooled and vacuum filtered (filter paper, Ø150 mm; Whatman International Ltd, 
UK). 700 mL of the filtered whey permeate was mixed with 150 mL of Mg-Mn-
Tween 80 solution (2.73 g/L magnesium sulphate heptahydrate, 0.37 g/L 
manganese (II) sulphate monohydrate and 6.67 g/L Tween 80) and autoclaved. To 
limit  Maillard  reaction,  87  mL  of  1  M  potassium  phosphate  buffer  (pH  6.6)  was  
added  to  a  mix  of  50  mL  of  yeast  extract  (20%  w/v)  and  13  mL  of  sodium  D/L-
lactate syrup (60% (w/w), synthetic) and autoclaved separately. The phosphate 
buffer was prepared by mixing approximately 50:50 (v/v) of 1 M di-potassium 
hydrogen phosphate (J.T. Baker, Deventer, the Netherlands) and 1 M potassium 
dihydrogen phosphate. At the time of usage, whey permeate and yeast extract parts 
were mixed in a sterile flasks in a 85:15 ratio.   
Cereal Matrices 
Two kinds of cereal matrices were prepared for the vitamin B12 production: (1) 
barley malt matrix (BMM; 33% w/v barley malt) and (2) barley flour matrix (BFM; 
6% w/v wholemeal barley flour). The cereal matrices were prepared by boiling 33% 
w/v barley malt (Laihian Mallas, Laihia, Finland) and 6% w/v wholemeal barley 
flour (Myllyn Paras, Hyvinkää, Finland) for 2 min. Both cereal matrices were then 
autoclaved and transferred to sterile falcon tubes for fermentation.   
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3.2.3 Culture Preparation 
Frozen cultures were thawed, inoculated on agar plate and incubated anaerobically 
at 30°C for 3-4 days. Three individual colonies were transferred to three falcon 
tubes, each filled with 5 mL of SWP medium (three biological replicates) and 
incubated anaerobically at 30°C for each strain. The strains were then subcultured 
(2% v/v) 3 times in triplicates for 3-4 days at 30°C in 5 mL of SWP medium. The 
incubation took place in anaerobic jars equipped with Anaerocult® A. 
3.2.4 Vitamin B12 Production in SWP Medium 
 
Figure 10. The flowchart of the 168-hour-vitamin B12 production in the SWP medium a. 
Vitamin B12 production in the SWP medium based on the type of precursors and b. 
Vitamin B12 production in the SWP medium based on the timing of precursors addition.  
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SWP I:Vitamin B12 Production with Addition of Precursors  
The 168-hour-fermentations were carried out in triplicate in 50 mL sterile falcon 
tubes (CELLSTAR®; Greiner Bio-one). The three subcultured strains were 
inoculated (1% v/v) in 20 mL of fresh SWP. Based on the type of precursors, three 
conditions  were  tested  in  SWP medium (Figure  10a):  (1)  with  cobalt  (II)  chloride  
(Sigma-Aldrich  Co.,  UK);  (2)  with  cobalt  (II)  chloride  and  DMBI;  and  (3)  with  
cobalt (II) chloride, riboflavin and nicotinamide (Sigma-Aldrich Co., China). The 
amount of cobalt (II) chloride, DMBI, riboflavin and nicotinamide were 5 mg/L, 15 
mg/L, 15.05 mg/L and 3.29 g/L, respectively, as recommended by Hoerig and Renz 
(1980) and Hugenschmidt et al. (2010). Cobalt (II) chloride was added at 0 h while 
the rest of precursors were added at 144 h. Before addition, all precursors were 
made in MQ-water and sterile filtered (0.2 µm filter; Acrodisc® 32 mm Syringe 
Filters; Pall Corporation, Cornwall, UK).  
All strains were incubated in anaerobic jars equipped with Anaerocult® A at 30°C 
for 72 h, followed by 96 h aerobic incubation. To obtain aerobic conditions, the 
tubes were slightly opened under sterile conditions, then closed again and incubated 
on  a  shaking  plate  (150  rpm,  CERTOMAT® MO II;  Sartorius  AG)  maintained  at  
30°C. After the addition of precursors at 144 h, the samples were further incubated 
aerobically for 24 h before harvesting vitamin B12. Sample aliquots were collected 
at 0, 72, and 168 h for pH, optical density, sugar and acid analyses. At 72 h, SWP 
medium sampling was done by taking 1.9-2.0 mL in Eppendorf tubes. After 
measuring the OD and pH, the tubes were centrifuged (12000 rpm, 10 min at 4°C; 
himac CT15RE, Hitachi Koki Co., Ltd., Japan). The supernatants were filtered 
through 0.2 µm filter and stored at -20°C for sugar and acid analyses. At the end of 
incubation, the strains grown in SWP medium were centrifuged (12000 rpm, 15 
min at RT; Centrifuge 5810R, Eppendorf AG, Germany). The supernatants were 
collected in 15 mL tubes at -20°C for sugar and acid analyses. The cell pellets were 
washed  with  10  mL  phosphate  buffered  saline  (PBS)  (Dulbecco  A;  OXOID  Ltd.,  
England) and centrifuged again. The second supernatants were discarded and the 
pellets were stored at -20°C for vitamin B12 analysis.  
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SWP II : Timing of Riboflavin/Nicotinamide Addition 
Two strains of P. freudenreichii (1 and 3) were tested. In this experiment the effect 
of precursor addition on vitamin B12 by the tested strains were evaluated. Similarly 
to the SWP I experiment, the strains were first inoculated (1% v/v) in 20 mL fresh 
SWP in 50 mL sterile falcon tubes. However, six treatments were carried out based 
on the type of precursors and the time of adding the precursors (Figure 10b): (1) 
non-supplemented SWP; (2) with cobalt (II) chloride; (3) with cobalt (II) chloride 
and DMBI; (4) with cobalt (II) chloride, riboflavin and nicotinamide (rib/nic; 0 h); 
(5) with cobalt (II) chloride and rib/nic (72 h); and (6) with cobalt (II) chloride and 
rib/nic  (144  h).  All  precursors  had  the  same  concentration  as  in  the  SWP  I  
experiment.  Cobalt  (II)  chloride was added at  0 h and DMBI was added at  144 h.  
All samples were then incubated in similar condition as in the SWP I experiment. 
Sample  aliquots  were  collected  at  0,  72,  and  168  h  for  pH,  optical  density,  sugar  
and organic acid analyses, followed by harvesting the cells for vitamin B12.  
One more thing that was different in the SWP II experiment was the preparation of 
riboflavin and nicotinamide solutions. In the first experiment, riboflavin and 
nicotinamide were prepared separately. However, riboflavin has poor solubility in 
water, making it difficult to dissolve. Frost (1946) reported that at pH 5.0 5% 
nicotinamide increased the solubility of riboflavin by nine times. Hence, different 
concentrations of riboflavin: 0.05%, 0.1%, 0.17%, 0.25% and 0.5% were diluted 
with 3.29 g nicotinamide in 10 mL water (Figure 11). The appropriate solution with 
the required concentration of precursors was then used in the vitamin B12 
production. 
41 
 
 
Figure 11. The solubility test of riboflavin and nicotinamide. Concentration of riboflavin: 
(1) 0.05%; (2) 0.1%; (3) 0.17%; (4) 0.25%; and (5) 0.5%. The upper picture shows the 
opaqueness of the solution increased as higher concentration of riboflavin was added. The 
bottom picture shows the insoluble riboflavin trapped in the filter. Solution 3 was chosen in 
the vitamin B12 production.  
3.2.5 Vitamin B12 Production in Cereal Matrices  
The 168-hour-fermentations were carried out in triplicate in 50 mL sterile falcon 
tubes. The three subcultured strains were inoculated (1% v/v) in 20 mL fresh barley 
malt and barley flour matrices. Based on the type of precursors, three conditions 
were tested in cereal matrices (Figure 12): (1) non-supplemented cereal matrices; (2) 
with DMBI; and (3) with cobalt (II) chloride and DMBI. The amount of cobalt (II) 
chloride and DMBI were 5 mg/L and 15 mg/L, respectively. Cobalt (II) chloride 
was added at 0 h while DMBI was added at 144 h. All samples were then incubated 
in similar condition as in the SWP experiment. The bacterial growth in cereal 
matrices was carried out by measuring viable cell counts (CFU/g). 
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Figure 12. Flowchart of 168-hour-vitamin B12 production in cereal matrices; barley malt 
matrix (BMM; 33% w/v barley malt) and barley flour matrix (BFM; 6% w/v wholemeal 
barley flour).  
3.2.6 Growth Measurements  
Optical density.  The  optical  density  (OD)  was  measured  at  600  nm  using  a  
spectrophotometer (Novaspec II, Amersham Pharmacia Biotech). The culture was 
diluted 20-fold and measured against fresh SWP medium.  
pH. At 72 h, the pH of culture samples was measured with pH-papers in the range 
of 3.6-6.1 (pH-Fix; Macherey-Nagel GmbH, Germany). The pH of 168 h culture 
samples was measured with pH meter (PHM220 MeterLab™; Radiometer 
Analytical SAS, France). The pH of the cereal matrices was measured at 0 h and 
168 h.  
Cell enumeration.  About  1  g  of  fermented  cereal  samples  were  serially  diluted  in  
PBS buffer and 100 µL of appropriate dilutions was plated by surface spreading 
method on agar plates for viable cell counts. The plates were incubated 
anaerobically  at  30°C  for  5-6  days.  Cell  counts  were  performed  and  mean  values  
were presented.      
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3.2.7 Vitamin B12 Analysis 
Vitamin B12 is  subject  to  light  degradation.  Thus,  extraction,  sample  enrichment,  
MBA and UHPLC analyses were conducted under subdued light.  
Preparation of Cyanocobalamin Standard Solution 
The preparation of standard solution was adapted and modified from Indyk et al. 
(2002). 4 mg of cyanocobalamin (Supelco, Bellefonte, PA, USA) was accurately 
weighed  into  a  20  mL  flask  and  diluted  to  volume  with  25%  ethanol  (Altia  Oyj,  
Rajamäki,  Finland),  called  as  the  stock  solution  I  (0.2  mg/mL).  To  determine  the  
actual concentration of the stock solution I, the solution was diluted 10-fold in 25% 
ethanol and its absorbance was measured against 25% ethanol at 361 nm using 
spectrophotometer (Lambda 25 UV/Vis; Perkin Elmer Inc., USA). The result was 
calculated using molar absorption coefficient (E361=28.1*103). The stock solution I 
was stable for 3 months at 4°C. 
At  the  day  of  analysis,  the  calibrant  was  prepared  by  diluting  the  stock  solution  I  
100-fold, called as the stock solution II (2 µg/mL). The stock solution II was further 
diluted 1:200, then 1:100 (0.1 ng/mL ) with 6.2 pH extraction buffer. 
Vitamin B12 Extraction 
SWP medium. The procedure for extracting vitamin B12 was adapted and modified 
from  Kelleher  and  Broin  (1991).  About  0.1  g  of  thawed  cell  pellets  was  weighed  
into a 30 mL-centrifuge tube and suspended in 10 mL of buffer (pH 4.5) containing 
8.3 mmol/L sodium hydroxide and 20.7 mmol/L glacial acetic acid (Riedel-de Haën 
GmbH, Seelze, Germany). 100 µL of 1% sodium cyanide (Sigma-Aldrich Chemie, 
Steinheim, Germany) was added into the tube, followed by heating the suspension 
for 30 min. in 100°C boiling water. The addition of cyanide was meant to convert 
any  forms  of  vitamin  B12 to cyanocobalamin. After cooling in ice bath, the tubes 
were then centrifuged (8000 rpm, 10 min at RT; Z 323, Hermle, Germany) and 
supernatants were collected in another 30 mL tube. The pellets were re-suspended 
with 5 mL of buffer (pH 6.2, adjusted with 10% sodium hydroxide) and centrifuged 
again. The second supernatants were combined with the first supernatants. The pH 
of supernatants was adjusted to 6.2 by adding 3% sodium hydroxide. The extracts 
were then filtered (90 mm qualitative filter paper; VWR International, Belgium) 
44 
 
into  a  25  mL  flask  and  diluted  to  volume  with  pH  6.2  buffer.  The  extracts  were  
ready for vitamin analysis by MBA or UHPLC or stored at -20°C. Using the same 
procedure as explained above, a blank sample and certified reference material (pig 
liver; BCR 487) were also extracted. The pig liver was used as the reference to 
evaluate the accuracy and precision of the quantification procedures.     
Cereal matrices. About 1-2 g of fermented cereal matrices was extracted with 10 
mL of buffer (pH 4.5).  To break down the starch, 1 mL of Į-amylase (50 mg/mL, 
produced from Aspergillus oryzae; Sigma-Aldrich Chemie, Steinheim, Germany) 
was added together with 100 µL of 1% sodium cyanide. The addition of amylase 
helped to ease filtration of the extracts for MBA and immunoaffinity purification. 
Prior to boiling, the tubes were incubated for 40 min at 37°C in a water bath 
equipped with a shaking plate. The tubes were then centrifuged, filtered and stored 
as described in SWP medium extraction.            
Sample Enrichment by Immunoaffinity Column 
Prior  to  UHPLC  analyses,  vitamin  B12 extracts from the cereal matrices were 
further purified and concentrated through “EASI-EXTRACT® Vitamin  B12” (R-
Biopharm Rhone Ltd, Glasgow, Scotland), an immunoaffinity column containing 
monoclonal antibody with high affinity to cyanocobalamin. The procedures were 
adapted and modified from Campos-Giménez et al. (2008), Marley et al. (2009) and 
Guggisberg et al. (2012). The thawed extracts were first filtered through 0.45 µm 
syringe filter (Acrodisc® 32 mm; Pall Corporation, Cornwall, UK). The sample 
extracts equivalent to the level of vitamin B12 above the quantitation limit (LOQ) of 
UHPLC was then purified by immunoaffinity column. The sample extracts loaded 
into the column should not exceed the saturation of the immunoaffinity column (1.0 
µg of vitamin B12).  
Firstly, the immunoaffinity columns were conditioned to room temperature. The 
storage buffer was drained by gravity. Appropriate volume of extracts (1-15 mL) 
was passed through the columns followed by washing with 10 mL of Milli-Q water 
(Q-POD® Element; Merck Millipore). The columns were drained by inserting 
about 50 mL of air using a syringe. The vitamin B12 absorbed in the column matrix 
was eluted with 3 mL of methanol and rinsed with additional 0.5 mL of methanol. 
20 mL of air was injected to remove any methanol from the columns. On a heating 
plate (50-60°C), the eluates were evaporated to dryness under a stream of nitrogen. 
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The samples were reconstituted in 300 µL of Milli-Q water. The extracts were then 
transferred  to  UHPLC  vials  (Waters  Corporation,  USA)  and  analysed  with  
UHPLC/UV.                
Analysis by Microbiological Assay (MBA) 
MBA protocols were adapted and modified from established reference procedures 
(Kelleher and Broin, 1991). The assay medium was first prepared by dissolving 3.1 
g of vitamin B12 assay medium and 75 µL of Tween 80 in 50 mL of Milli-Q water, 
followed by boiling for 2 min. After cooling, the pH was adjusted to 6.2 with 10% 
NaOH. The medium was filtered into a sterile glass bottle. The filtered medium was 
kept on ice until inoculation with Lactobacillus delbrueckii (ATCC 7830). The 
MBA analysis was performed in 96-well microtiter plates (Corning Inc., New York, 
USA). A standard curve was prepared in quadruplicate, comprising eight 
cyanocobalamin concentrations from 0-8 pg (0-80 µL)/well. Extraction buffer (20-
100 µL) was then pipetted into these wells so that each well contained 100 µL. 
Based on an estimation of vitamin B12 content (20-50 pg/mL), two dilutions of each 
sample extract were prepared in 10 mL flasks with pH 6.2 extraction buffer. 100 µL 
of  vitamin  B12 extracts was pipetted to the remaining wells. A vial of glycerol-
cryopreserved L. delbrueckii was rapidly thawed. 100 µL of L. delbrueckii culture 
was then added to the cooled 50 mL of assay medium. 200 µL of inoculated 
medium was added to every well using an eight-channel pipette. Each plate was 
covered with a plate sealer and incubated for 19 hours at 35°C. The OD of the wells 
was then measured at  595 nm on a microplate reader (Multiskan EX; Labsystems, 
Finland). Vitamin B12 concentrations were calculated according to the calibration 
curve and expressed in µg/mL and ng/g for vitamin B12 production  in  the  SWP  
medium and the cereal matrices, respectively.         
Analysis by Ultra High-Performance Liquid Chromatography (UHPLC) 
Vitamin B12 was  also  quantified  with  a  newly  developed  UHPLC  method  
(Chamlagain et al. submitted). The separation was performed on a Waters Acquity 
UHPLC  system  (Milford,  Massachusetts,  USA)  using  a  2.1  X  100  mm  High  
Strength  Silica  (HSS)  T3  1.8  µm  column.  The  elution  of  cyanocobalamin  was  
detected at 361 nm on a Waters photodiode array detector. The method used two 
mobile phases where solution A was 0.025% (v/v) trifluoroacetic acid (TFA) in 
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Milli-Q  water  and  solution  B  was  0.025%  TFA  in  acetonitrile.  All  solvents  were  
previously filtered through 0.2 µm hydrophilic polypropylene membrane filters 
(Pall Corporation, Michigan, USA). Six concentrations of cyanocobalamin (0.016-
0.8 ng/µL) were prepared from the stock solution I for a standard curve. The sample 
injection volume was 5-15 µL (vitamin B12 extracts) and 15 µL (cyanocobalamin 
standards). A flow rate of 0.320 mL/min was maintained throughout the duration of 
each run (10 min). Elution was done in the following conditions: 0-0.50 min, 95% 
A and 5% B were combined in a linear gradient; 0.50-5.00 min, 95% A and 5% B 
were combined in a linear gradient to a final proportion of 60% A and 40% B; 5.00-
6.00 min, 60% A and 40% B were maintained; 6.00-7.00 min, 60% A and 40% B 
were combined in a linear gradient to a final proportion of 95% A and 5% B, which 
were maintained until 10.00 min. The final results were expressed in µg/mL and 
ng/g for vitamin B12 production in SWP medium and cereal matrices, respectively.     
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3.3 Results 
According to the media (SWP and cereal matrices) utilized to produce vitamin B12, 
the results are divided into three parts: (1) vitamin B12 production in DMBI and 
riboflavin/nicotinamide added SWP (SWP I); (2) vitamin B12 production with 
different timing of riboflavin/nicotinamide addition (SWP II) and (3) vitamin B12 
production in the cereal matrices. In each part, the results of growth measurements 
(pH, OD and cell counts) are presented, followed by vitamin B12 concentrations.     
3.3.1 Vitamin B12 Production in DMBI and Riboflavin/Nicotinamide Added SWP  
3.3.1.1 Growth of Propionibacterium Strains  
pH  
The pH of the SWP medium fermented by the P. freudenreichii strains during the 
168-hour-vitamin B12 production is shown in Figure 13. Within 72 hours of 
anaerobic fermentation, a decrease from pH 6.5 to around pH 5.0-5.3, depending 
on  the  strains,  was  observed.  After  96  hours  of  aerobic  fermentation,  the  pH of  
the SWP medium further reduced to pH 4.9-5.0 for all three strains.       
 
Figure 13. The pH in of SWP medium during the 168-hour-vitamin B12 production by 
the P. freudenreichii strains 1, 2 and 3.    
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Optical Density  
The bacterial growth in the SWP I experiment is presented in Figure 14. At 72 h, 
the  strain  1  showed  the  highest  biomass  growth  with  the  average  OD  of  11.0.  
Approximately half OD compared to that in the strain 1 was observed in the strain 
2 and 3 with the average of 5.9 and 5.8, respectively. However, following 96 
hours of aerobic fermentation, higher increase of OD was observed in the SWP 
medium fermented by the strain 2 and strain 3, giving the average of 7.9 and 7.8, 
respectively. While at 168 h, the strain 1 showed insignificant increase of OD 
(P=0.166), giving the final OD of 11.6.    
 
Figure 14. The optical density of the P. freudenreichii strains  1,  2  and  3  in  the  SWP  
medium with the addition of cobalt (II) chloride, DMBI, and riboflavin/nicotinamide 
during the 168-hour-vitamin B12 production.    
3.3.1.2 Vitamin B12 Content  
Effect of DMBI Supplementation 
The effect of various precursors on the level of vitamin B12 produced by the three 
P. freudenreichii strains is shown in Figure 15. The addition of 15 mg/L DMBI 
increased vitamin B12 content by almost 2-fold to 1.7 µg/mL in the SWP medium 
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inoculated with the strain 1. An increase of vitamin B12 content due to the 
addition of DMBI was also observed in the medium inoculated with the strain 2, 
yielding up to 3-fold rise to 1.9 µg/mL. On the contrary, compared to the vitamin 
B12 content produced in the cobalt-added SWP medium, the vitamin B12 
production did not increase with the addition of DMBI in the SWP medium 
inoculated with the strain 3.   
Effect of Riboflavin/Nicotinamide Supplementation 
The addition of 15.05 mg/L of riboflavin and 3.29 g/L of nicotinamide did not 
increase vitamin B12 production in the SWP medium fermented by the strain 1. In 
the SWP medium fermented by the strain 2, additional supplementation of 
riboflavin/nicotinamide led to a similar (P=0.358) level of vitamin B12 as vitamin 
B12 content produced in SWP medium supplemented by only cobalt (II) chloride. 
Strain  3  was  the  only  strain  showing  an  increase  in  vitamin  B12 concentration 
with the riboflavin/nicotinamide supplementation on day 6 (144 h), yielding 1.1 
µg/mL of vitamin B12. 
 
 
Figure 15. The vitamin B12 concentration produced by the P. freudenreichii strains 1, 2 
and  3  in  the  SWP  medium  supplemented  with  cobalt  (II)  chloride,  DMBI,  and  
riboflavin/nicotinamide. Cobalt (II) chloride was added at 0 h, while DMBI and 
riboflavin/nicotinamide were added at 144 h. Vitamin B12 was quantified by UHPLC 
(means and standard deviations of 3 biological replicates). 
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3.3.1.3 Analysis of Vitamin B12 by MBA and UHPLC 
Table 7 shows the vitamin B12 concentrations produced in the SWP I medium by 
the P. freudenreichii strains, analysed by the MBA and the UHPLC method. The 
MBA-determined vitamin B12 concentrations were up to 34% higher than the 
UHPLC-measured vitamin B12 concentrations. The ratio of the vitamin B12 levels 
obtained by the two methods differed depending on the P. freudenreichii strains. 
Both methods showed similar vitamin B12 levels for the samples fermented by the 
strain 3, with average discrepancy of 9.7%. While bigger discrepancy between the 
two methods was observed in the samples fermented by the strain 1 and 2, giving 
a difference of 20.5% and 28.9%, respectively.  
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Table  7. The vitamin B12 concentrations  produced by the three P. freudenreichii strains in the SWP medium, analysed by microbiological assay and the 
UHPLC method. 
Conditions 
Strains 
1 2 3 
Vit. B12 conc. (µg/mL) Vit. B12 conc. (µg/mL) Vit. B12 conc. (µg/mL) 
MBA UHPLC MBA/UHPLC MBA UHPLC MBA/UHPLC MBA UHPLC MBA/UHPLC 
SWP+Co 1.20±0.26a 0.97±0.07b 1.24 0.76±0.13a 0.59±0.09a 1.28 0.84±0.03a 0.82±0.03a 1.02 
SWP+Co+DMBI 2.03±0.02a 1.72±0.04a 1.18 2.34±0.11a 1.89±0.06a 1.24 0.88±0.03a 0.83±0.03a 1.05 
SWP+Co+Rib/Nic(144) 0.84±0.02b 0.71±0.03a 1.19 0.85±0.13b 0.63±0.06b 1.34 1.33±0.07a 1.10±0.08a 1.21 
a All values obtained represent mean ± SEM (n = 3) 
b All values obtained represent mean ± SEM (n = 2) 
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3.3.2 Vitamin B12 Production with Different Timing of Riboflavin/Nicotinamide 
Addition 
3.3.2.1 Growth of Propionibacterium Strains 
pH 
The  changes  in  the  pH  of  the  SWP  II  experiment  (Figure  16)  showed  similar  
trend  to  the  SWP  I  experiment  (Figure  13).  After  3  days  of  anaerobic  
fermentation, the initial pH 6.5 decreased to pH 5.0 and 5.2 for the strain 1 and 3, 
respectively. Further reduction of pH during the 4 days of aerobic fermentation 
was also observed in the strain 1 and 3, giving the final values of pH 4.8 and 5.0, 
respectively.   
 
Figure 16. The pH in the SWP medium during the 168-hour-vitamin B12 production by 
the P. freudenreichii strains 1, 2 and 3.   
Optical Density 
The  changes  in  the  OD  in  the  SWP  II  experiment  (Figure  17)  showed  similar  
trends to the OD in the SWP I experiment (Figure 14), particularly in the samples 
treated with the same conditions. Approximately twice higher OD in the strain 1 
than in the strain 3 was observed in all six conditions after 72 h of anaerobic 
fermentation. At the end of fermentation, most of the samples showed further 
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biomass  growth,  in  which  the  increase  of  the  OD in  the  strain  3  (P=0.001)  was  
significantly higher than that in the strain 1 (P=0.210). Furthermore, the timing of 
adding riboflavin/nicotinamide seemed to influence the growth of the P. 
freudenreichii strains, particularly for the strain 3. When riboflavin/nicotinamide 
was  added  at  0  and  72  h,  the  OD  of  the  strain  3  increased  from  6.9  to  9.5  and  
from 6.7 to 9.4,  while a slight increase of the OD from 7.4 to 7.8 was observed 
when riboflavin/nicotinamide was added at 144 h. 
 
 
Figure 17. The optical density of the P. freudenreichii strains 1 and 3 in the SWP medium, 
treated with six conditions during the 168-hour-vitamin B12 production. Riboflavin and 
nicotinamide were added at different time points; 0 h, 72 h and 144 h.  
3.3.2.2 Vitamin B12 Content 
Since cobalt is the central atom of vitamin the B12 structure, the effect of cobalt 
(II) chloride addition on vitamin B12 production was investigated by fermenting 
SWP medium with P. freudenreichii strains  without  the  addition  of  cobalt  (II)  
chloride or any other precursors. The effect of different timing in adding 
riboflavin/nicotinamide on vitamin B12 conentrations was also investigated.  
0,00
2,00
4,00
6,00
8,00
10,00
12,00
14,00
16,00
18,00
72 h 168 h 72 h 168 h
Strain 1 Strain 3
O
D
SWP SWP+Co SWP+Co+DMBI
SWP+Co+Rib/Nic (0) SWP+Co+Rib/Nic (72) SWP+Co+Rib/Nic (144)
54 
 
Effect of Cobalt Supplementation 
The  effect  of  cobalt  addition  on  vitamin  B12 concentrations was quite evident. 
Without the addition of any precursors, the strain 1 and 3 produced lowest yields 
of  vitamin  B12 (Figure 18). With the supplementation of cobalt (II) chloride, an 
increase  of  vitamin  B12 content  up  to  4-fold  was  observed  in  the  strain  1  and  3,  
yielding 0.9 and 0.7 µg/mL of vitamin B12, respectively.        
Effect of DMBI Supplementation 
Compared  to  the  vitamin  B12 contents produced in the SWP I experiment under 
the  same  condition  (Figure  15),  additional  supplementation  of  DMBI  in  the  
cobalt-added  SWP  medium  showed  similar  vitamin  B12 concentrations (Figure 
18), yielding 1.7 and 0.8 µg/mL for the strains 1 and 3, respectively. As expected, 
insignificant increase (P=0.065) due to the addition of DMBI was observed in the 
samples fermented by the strain 3.      
Effect of Timing of Riboflavin/Nicotinamide Supplementation 
The supplementation of riboflavin/nicotinamide enhanced vitamin B12 production 
only  in  the  samples  inoculated  with  the  strain  3  (Figure  18),  which  was  also  
observed in the SWP I experiment (Figure 15). Compared to the vitamin B12 
contents produced in the unsupplemented SWP medium, approximately 4-9 fold 
rise of vitamin B12 amount was produced by the strain 3, depending on the time of 
addition of riboflavin/nicotinamide. The timing of adding riboflavin/nicotinamide 
influenced the amount of vitamin B12; the strain 1 and 3 synthesized higher 
vitamin B12 content when riboflavin/nicotinamide was added at the beginning of 
fermentation than at the latter stage. However, more significant increase of 
vitamin B12 due to the different timing in adding the precursors was observed in 
the strain 3 (P=0.006) than in the strain 1 (P=0.028). In the samples inoculated 
with the strain 3, the addition of riboflavin/nicotinamide at 0 h and 72 h produced 
2-fold vitamin B12 concentrations than that produced when the precursors were 
added at 144 h, yielding 2.2, 2.1 and 1.1 µg/mL of vitamin B12, respectively.  
Particularly for the strain 3, higher vitamin B12 concentrations due to the early 
addition of riboflavin/nicotinamide were also supported by higher OD after 168 
hours of fermentation (Figure 17).  
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Figure 18. The vitamin B12 concentrations produced by the P. freudenreichii strain 1 and 
3 in the SWP medium, treated with six conditions during the 168-hour-vitamin B12 
production. Riboflavin and nicotinamide were added at different time points; 0 h, 72 h 
and 144 h. Vitamin B12 was quantified by UHPLC (means and standard deviations of 3 
biological replicates). 
3.3.2.3 Analysis of Vitamin B12 by MBA and UHPLC 
Table  8  shows  the  vitamin  B12 concentrations produced in the SWP medium 
under  six  different  conditions,  analysed  by  MBA  and  UHPLC.  The  
MBA/UHPLC ratio in the SWP II experiment showed similar trends to the SWP I 
experiment; all MBA-determined vitamin B12 concentrations were higher than 
vitamin  B12 levels  measured  by  the  UHPLC method.  However,  compared  to  the  
MBA/UHPLC ratio in the SWP I experiment, closer discrepancy was achieved, 
giving difference between 2-20%. 
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Table 8. The vitamin B12 concentrations produced by the two P. freudenreichii strains in 
the SWP medium, analysed by microbiological assay and UHPLC method. 
Conditions 
Strains 
1 3 
Vit. B12 conc. (µg/mL) Vit. B12 conc. (µg/mL) 
MBA UHPLC 
MBA/ 
UHPLC 
MBA UHPLC 
MBA/ 
UHPLC 
SWP 0.21±0.01a 0.19±0.01a 1.07 0.25±0.01a 0.24±0.01a 1.02 
SWP+Co 1.11±0.02a 0.93±0.03a 1.19 0.86±0.01a 0.74±0.03a 1.17 
SWP+Co+DMBI 1.78±0.01a 1.66±0.01a 1.07 0.91±0.03a 0.82±0.02a 1.11 
SWP+Co+Rib/Nic(0) 1.28±0.05a 1.12±0.08a 1.14 2.34±0.18a 2.20±0.10a 1.07 
SWP+Co+Rib/Nic(72) 1.13±0.04a 1.05±0.07a 1.08 2.20±0.07a 2.12±0.07a 1.04 
SWP+Co+Rib/Nic(144) 0.88±0.03a 0.81±0.02a 1.09 1.18±0.04a 1.10±0.17a 1.07 
a All values obtained represent mean ± SEM (n = 3) 
3.3.3 Vitamin B12 Production in Cereal Matrices 
3.3.3.1 Growth of Propionibacterium Strains 
pH 
The change of the pH during the 168-hour-fermentation in the BMM and BFM is 
shown in Figure 19. At the end of fermentation, the pH of the BMM samples 
fermented by the strains 1, 2 and 3 decreased from pH 5.6 to pH 4.6, 4.5 and 4.5, 
respectively. However, fermentation did not markedly reduce the pH in the barley 
BFM  samples;  the  pH  at  168  h  remained  close  to  the  initial  pH  of  the  matrix  
(Figure 19).  
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Figure 19. The pH in the cereal matrices during the 168-hour-B12 production by the 
P.freudenreichii strains  1,  2  and  3.  BMM:  33%  w/v  barley  malt  and  BFM:  6%  w/v  
wholemeal barley flour. 
Cell Counts 
At the beginning of vitamin B12 production, the cell counts in both matrices were at 
the  same  level  (Figure  20),  with  average  of  8.0  and  8.1  log  CFU/g  for  P. 
freudenreichii strains  grown  in  the  BMM  and  the  BFM,  respectively.  After  72  
hours of anaerobic fermentation, the bacterial population of P. freudenreichii 
strains in the fermented BMM increased up to 60, 35 and 120-fold for the strain 1, 2 
and  3.  While  at  72  h,  a  log  factor  increase  of  cell  counts  was  observed  in  the  
fermented BFM. The cell counts in both matrices remained the same until the end 
of fermentation, giving the final average counts of 9.8 and 8.9 log CFU/g for 
fermented BMM and BFM, respectively.       
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Figure 20.  The  cell  counts  (log  CFU/g)  of  the  P. freudenreichii strains  1,  2  and  3  in  the  
cereal matrices during the 168 h-vitamin B12 production. BMM: 33% w/v barley malt and 
BFM: 6% w/v wholemeal barley flour.  
3.3.3.2 Vitamin B12 Content 
The vitamin B12 levels in the fermented cereal matrices were obtained from MBA 
since only few fermented cereal samples were analysed by the UHPLC method.  
Barley Malt Matrix 
Without the addition of any precursors, the fermented BMM contained 45.1, 23.1 
and 21.5 ng/g of vitamin B12 (Figure  21),  produced  by  the  strains  1,  2  and  3,  
respectively. No increase of vitamin B12 contents was observed in any of the 
samples  supplemented  with  DMBI.  However,  when  DMBI  and  cobalt  (II)  
chloride were added to the matrix, a considerable increase up to 40-fold was 
observed, yielding 1407.1, 1032.9 and 988.9 ng/g, produced by the strains 1, 2 
and 3, respectively.  
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Figure 21. The vitamin B12 concentrations produced by the P. freudenreichii strains 1, 2 
and 3 in the barley malt matrix, treated under three conditions during the 168-hour-
vitamin B12 production (means and standard deviations of 3 biological replicates).   
Barley Flour Matrix 
The influence of DMBI and cobalt (II) chloride addition on vitamin B12 
production in the fermented BFM showed similar trends (Figure 22) to the 
vitamin  B12 production in the fermented BMM (Figure 21).  However,  all  strains 
grown in  the  BFM produced  relatively  low levels  of  vitamin  B12; the maximum 
vitamin B12 production was achieved by the strain 1 at 80.1 ng/g.  
When precursors were not added, strains 1, 2 and 3 produced 10.2, 8.0 and 12.2 
ng/g of vitamin B12, respectively. No increase of vitamin B12 contents due to the 
addition  of  DMBI  was  observed.  The  combination  of  DMBI  and  cobalt  (II)  
chloride increased the amount of vitamin B12 up to 8-fold, yielding 80.1 and 50.1 
ng/g for the strains 1 and 2, respectively. 
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Figure 22. The vitamin B12 concentrations produced by the P. freudenreichii strains 1, 2 
and 3 in the barley flour matrix, treated under three conditions during the 168-hour-
vitamin B12 production (means and standard deviations of 3 biological replicates).  
3.3.3.3 Analysis of Vitamin B12 by MBA and UHPLC 
Vitamin B12 quantification by the UHPLC method was only applied to the 
fermented BMM samples due to the infeasibility to enrich the fermented BFM 
samples through immunoaffinity columns. Most of the samples analysed by the 
MBA showed higher vitamin B12 contents than those measured by the UHPLC 
method (Table 9), having discrepancy up to 113.2%. The amount of vitamin B12 
in the samples influenced the variance between the two methods. In the samples 
supplemented with DMBI and cobalt (II) chloride, which contained quite much 
higher vitamin B12 had small difference of 4.7%, 9.0% and 4.8% for the strains 1, 
2 and 3, respectively. While greater difference was observed in the samples that 
contained low levels of vitamin B12. 
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Table  9. The vitamin B12 concentrations produced by the three P. freudenreichii strains in 33% w/v barley malt matrix, analysed by microbiological assay and 
UHPLC. 
Conditions 
Strains 
1 2 3 
Vit. B12 conc. (ng/g) Vit. B12 conc. (ng/g) Vit. B12 conc. (ng/g) 
MBA UHPLC MBA/UHPLC MBA UHPLC MBA/UHPLC MBA UHPLC MBA/UHPLC 
BMM 45.14±5.73a 37.14±3.20b 1.22 23.07±1.01a 10.96c 2.11 21.52±1.19b 10.09c 2.13 
BMM+DMBI 40.68±3.18a 37.50c 1.08 27.30±2.60a 14.33c 1.68 26.16±1.53a 19.55c 1.34 
BMM+DMBI+Co 1407.13±35.09a 1476.99±59.81a 0.95 1032.94±79.12b 1134.60
c 0.91 988.95±11.33a 944.03±48.40
a 1.05 
a All values obtained represent mean ± SEM (n = 3) 
b All values obtained represent mean ± SEM (n = 2) 
c Values obtained from one replicate.   
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3.4 Discussions 
3.4.1 Effect of Precursors on the Growth of Propionibacterium Strains 
The  pH  of  the  SWP  medium  decreased  from  pH  6.5  to  pH  5.0-5.3  after  72  h  of  
fermentation and further declined to pH 4.9-5.0 at the end of fermentation. This pH 
profile was typically found in all fermentations. Utilizing P. freudenreichii and 
Propionibacterium sp., the pH profile during vitamin B12 production in SWP 
medium done by Hugenschmidt et al. (2010) was alike; the pH of the cultures was 
between 5.5-6.2 after 72 hours and decreased to less than 5.0 after 168 hours of 
fermentation.  
Depending on the three P. freudenreichii strains,  slight  differences  of  pH  in  the  
SWP medium were observed after 168 hours of fermentation. Samples inoculated 
with the strain 1 had the lowest pH at 4.87 followed by the strain 2 and strain 3 at 
pH 4.95 and 5.04, respectively. The difference of the pH could be influenced by the 
type and the concentration of acids produced by each strain during the fermentation. 
To confirm this observation, analysis of organic acids could be performed, which 
was not included in this study.   
Furthermore, the addition of various precursors did not seem to influence the pH of 
the SWP medium and the cereal matrices. This finding was in agreement with the 
results of Marwaha et  al.  (1983),  who studied the influence of the DMBI addition 
on lactose utilization in vitamin B12 production by three strains of 
Propionibacterium. Utilizing whey permeate as the fermentation medium Marwaha 
et al. (1983) reported that the degree of lactose assimilation during vitamin B12 
production  was  not  influenced  by  the  addition  of  DMBI  at  various  time  intervals  
(Figure 23a). Although lactose utilization was not measured in this study, besides 
producing vitamin B12, the P. freudenreichii strains also converted lactose to 
organic acids such as propionic acid and acetic acid (Colomban 1993; Hunik 1999), 
which reduced the pH during the fermentation.   
In the fermented BFM, the pH of the samples remained close to the initial pH of the 
matrix (Figure 19), which could be influenced by the lower availability of carbon 
sources  in  the  BFM  (6%  w/v)  than  in  the  BMM  (33%  w/v).  Since  the  BFM  
contained fewer sugars and other nutrients to be utilized by the P. freudenreichii 
strains, lower concentration of organic acid could have been produced, explaining 
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no change in the pH of at the end of fermentation. Organic acids analysis could also 
be performed to confirm this observation.  
Based  on  the  OD  in  the  SWP  medium  (Figure  14  and  17),  the  strain  1  showed  
approximately twice higher OD than the OD of the other two strains. The 
availability of carbon sources in the cereal matrices might also influence the cell 
counts. The strains grown in the BMM had approximately a log factor higher cell 
counts than the strains grown in the BFM (Figure 20). Both the OD and cell counts 
revealed that the addition of cobalt, DMBI, riboflavin and and nicotinamide neither 
enhance nor inhibit the growth of P. freudenreichii strains. Interestingly, the 
addition of riboflavin/nicotinamide at different phases of fermentation enhanced the 
growth of P. freudenreichii strains,  particularly  the  strain  3  (Figure  17).  The  
addition of riboflavin/nicotinamide at 0 and 72 h markedly increased the OD of the 
strain 3. While a slight increase of OD was observed when the precursors were 
added  at  144  h.  The  effect  of  timing  of  adding  precursor  on  the  growth  of  the  
cultures during vitamin B12 production was also reported by Marwaha et al. (1983). 
Although they did not test the effect of riboflavin/nicotinamide, they observed the 
influence  of  DMBI  addition  at  different  phases  of  fermentation  on  the  growth  of  
Propionibacterium cultures  (Figure  23b).  Contrary  with  the  addition  of  
riboflavin/nicotinamide, the study showed the maximum biomass concentrations 
were achieved when DMBI was added after 144 h of fermentation and the addition 
of DMBI at early stages of fermentation inhibited the growth of the organisms.    
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Figure 23.  (a.) Influence of DMBI addition on lactose utilization during vitamin B12 
production; (b.) The effect of timing of DMBI addition on the growth of three 
Propionibacterium cultures: P. shermanii 566, P. shermanii and Propionibacterium arl 
AKU 1251. ż, 0 h; +, 48 h; Ɣ, 96 h; ¨ 144 h (Marwaha et al. 1983).  
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3.4.2 Effect of Precursors on Vitamin B12 production 
3.4.2.1 Effect of Cobalt Supplementation  
The availability of cobalt is crucial for the synthesis of vitamin B12. As the central 
atom of the planar ring system in vitamin B12 structure, cobalt has been suggested 
as the limiting factor for vitamin B12 biosynthesis (Panzeca et  al.  2008).  5 mg/L 
cobalt (II) chloride was added in this study, as suggested by Hugenschmidt et al. 
(2011), who obtained a maximum vitamin B12 yields after testing different cobalt 
chloride concentrations (0, 0.01, 0.05 and 5 mg/L) in SWP medium without the 
DMBI addition. The addition of cobalt (II) chloride largely affected the vitamin 
B12 yields of P. freudenreichii strains in this study. Without the addition of cobalt 
or any other precursors, all three strains produced the lowest but also similar 
vitamin B12 yields, either in the SWP medium or the cereal matrices. An increase 
of vitamin B12 yields up to 4-fold was observed in the cobalt supplemented-SWP 
medium depending on the strains (Figure 18).  
3.4.2.2 Effect of DMBI Supplementation  
In addition to cobalt, the availability of DMBI (the lower ligand of vitamin B12) is 
also crucial in forming the vitamin. When DMBI is absence or replaced by other 
substituents, such as adenine, analogues of vitamin B12 called pseudo-vitamin B12 
are formed (Martens et al. 2002). These corrinoids have no vitamin activity in 
mammals (Gregory, 1996).  
Despite the ability of P. freudenreichii strains to grow under aerobic conditions, 
the maximum production of corrinoids (precursors of vitamin B12) is achieved 
under anaerobic fermentation (Quesada-Chanto et al. 1998). On the contrary, the 
biosynthesis and attachment of DMBI in P. freudenreichii strains require oxygen 
(Renz 1970). Thus, to achieve maximum vitamin B12 yields in our study, the 
vitamin  B12 production by P. freudenreichii strains was performed in two-stage 
fermentation consisting of 72 hours of anaerobic incubation followed by 96 hours 
of aerobic fermentation, as suggested by Martens et al. (2002). 
Depending on the strains, it has been shown that propionic acid bacteria are able 
to produce their own DMBI (Friedman and Cagen 1970), but it is often added to 
increase vitamin B12 yields. In this study, DMBI was added at the later stage of 
fermentation  (144  h)  since  supplementation  of  DMBI  at  early  stages  of  
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fermentation inhibits the growth of Propionibacterium, resulting lower yields of 
vitamin B12. The low yields of B12 with early addition of DMBI could be due to 
the increased energy consumption by the cultures to overcome the inhibitory 
effect of DMBI rather than its utilization for the growth and metabolite formation 
processes (Marwaha et al. 1983).  
The  two-stage  fermentation  and  the  addition  of  15  mg/L  DMBI  in  cobalt-
supplemented SWP medium led to maximum vitamin B12 production by the strain 
1 and 2, yielding 1.7 and 1.9 µg/mL, respectively. These results were comparable 
with the study conducted by Hugenschmidt et al. (2010), who achieved maximum 
vitamin  B12 production at 2.5 µg/mL, produced by P. freudenreichii DF15 in 
SWP medium supplemented with 5 mg/L cobalt (II) chloride and 15 mg/L DMBI. 
Without the DMBI addition, the strain 1 and 2 produced approximately one third 
of vitamin B12 yields in the cobalt-supplemented SWP medium. On the contrary, 
compared to the vitamin B12 yields in the cobalt-supplemented SWP medium 
(Figure 15 and 18), insignificant increase (P=0.065) of vitamin B12 yields due to 
DMBI addition was observed in the samples fermented with the strain 3. When 
cobalt  was  not  added,  low  vitamin  B12 yields were observed in DMBI-
supplemented cereal matrices with the amount below 50 ng/g of vitamin B12. 
However, the combination of cobalt and DMBI markedly increased the vitamin 
B12 yields up to 8- and 40-fold in the BFM (Figure 22) and the BMM (Figure 21), 
respectively.  
3.4.2.3 Effect of Riboflavin/Nicotinamide Supplementation  
P. freudenreichii was  demonstrated  to  utilize  riboflavin  as  precursor  in  DMBI  
biosynthesis (Renz 1970) whose transformation appeared to be stimulated by 
nicotinamide (Hoerig and Renz 1980). Therefore, this study investigated the 
effect of riboflavin/nicotinamide addition on vitamin B12 production. According 
to  the  level  of  vitamin  B12 produced in this study, the capacity of P. 
freudenreichii strains  in  vitamin  B12 production varied depending on the type of 
precursors added in the SWP medium. As shown in Figure 15, the strain 1 and 2 
reached maximum vitamin B12 production when cobalt-added SWP medium was 
supplemented  with  DMBI.  While  under  the  same  conditions,  the  strain  3  
produced maximum vitamin B12 yields when riboflavin/nicotinamide was added.   
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These observations were in agreement with the results of Hoerig and Renz (1980), 
who studied the DMBI-forming system in two subspecies of P. freudenreichii 
strains: P. freudenreichii subsp. freudenreichii and P. freudenreichii subsp. 
shermanii. They found that intact cobalt-free-grown P. freudenreichii subsp. 
freudenreichii ATCC 8207 cells produced DMBI from riboflavin whereas under 
the same conditions P. freudenreichii subsp. shermanii St  33  cells  formed  only  
trace amounts of DMBI, confirming P. freudenreichii strains react differently 
towards the addition of DMBI, riboflavin and nicotinamide. This observation thus 
showed  the  diversity  of  Propionibacteria in  terms  of  DMBI-forming  system  on  
vitamin  B12 production. Despite acknowledging that the three P. freudenreichii 
had different capacity of vitamin B12 production in the presence of 
riboflavin/nicotinamide, the exact mechanism of how these three strains utilized 
riboflavin/nicotinamide to form DMBI was not well-understood.     
3.4.3 Effect of Timing of Riboflavin/Nicotinamide Supplementation 
The timing in adding riboflavin/nicotinamide largely affected the vitamin B12 
concentrations in the SWP medium. Both strain 1 and 3 synthesized higher vitamin 
B12 yields when riboflavin/nicotinamide was added at the beginning of 
fermentation than at the latter stage. However, a significant increase of B12 yields 
was particularly observed in the samples inoculated with the strain 3. Compared to 
the vitamin B12 yields when riboflavin/nicotinamide was added at 144 h, the strain 
3 produced 2-fold higher vitamin B12 concentrations when the precursors were 
added at 0 and 72 h (Figure 18), yielding 2.2 and 2.1 µg/mL of vitamin B12, 
respectively. The effect of timing of riboflavin/nicotinamide addition on vitamin 
B12 yields could be due to the growth enhancement of P. freudenreichii strain 3 that 
was also observed with early addition of riboflavin/nicotinamide; allowing the 
strain  to  produce  more  vitamin  B12. Furthermore, since lag phase occurs when 
nicotinamide stimulates DMBI formation from riboflavin (Hoerig and Renz 1980), 
the addition of riboflavin/nicotinamide at early stages compensated the time 
consumed during the lag phase and gave longer time for the transformation of 
DMBI, providing more available DMBI. However, to confirm if more DMBI is 
formed when riboflavin/nicotinamide is added at early stages, the concentrations of 
DMBI should also be measured, which was not covered in this study. 
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3.4.4 Vitamin B12 Production in Cereal Matrices 
Quantified by MBA (L. delbrueckii ATCC 7830), the maximum vitamin B12 yield 
in the cereal matrices was 1.41 µg/g, produced by the strain 1 in DMBI- and cobalt-
supplemented BMM. This amount of vitamin B12 was markedly higher compared to 
the reported vitamin B12 yields in a commercial fermented cereal product, tempe. 
Tempe is made by soaking, dehulling and cooking soybeans (or other legumes, 
seeds and cereal grains). The soybeans are then surface-dried and inoculated with 
the spores of Rhizopus spp. (R. oligosporus, R. stolonifer, R. arrhizus and R. 
oryzae), forming compact patties during the solid substrate fermentation (SSF). 
However, the moulds do not synthesize physiologically active vitamin B12. Instead, 
vitamin B12 is produced by contaminant bacteria such as Bacillus megaterium, Cit. 
freundii, Enterobacter cloacae, Escherichia coli, Kl. pneumoniae, Kl. terrigena, Kl. 
planticola, Kl. ozeanae and Streptomyces olivaceus that occur during soaking 
and/or SSF.  
Liem et al. (1977) isolated and purified vitamin B12-producing bacterium 
(unidentified) from tempe (Tjing Giok Tan, Toronto, Canada). Reinoculation of this 
bacterium into sterile soybean produced 0.15 µg/g of vitamin B12 (MBA; L. 
leichmannii ATCC 7830). Keuth and Bisping (1993) also investigated the vitamin 
B12 production in tempe and found Cit. freundii and K. pneumoniae were the best 
vitamin B12-producing bacteria in tempe. By adding Cit. freundii (isolate 259) and 
K. pneumoniae (isolate 274) at the beginning of tempe fermentation, Keuth and 
Bisping (1994) achieved 0.15 and 0.14 µg/g of vitamin B12 (MBA; L. leichmannii 
ATCC 7830) after 34 h of SSF at 32°C. With the high vitamin B12 produced in the 
BMM, this study hence showed the promising possibilities to produce high amount 
of vitamin B12 in other plant-based food matrices through in situ fermentation.  The 
lower  availability  of  sugars  in  the  BFM  (6%  w/v)  than  in  the  BMM  (33%  w/v)  
might also influence the level of vitamin B12 in the fermented cereal matrices since 
relatively low levels of vitamin B12 produced  in  the  fermented  BFM  (max.  
production of 0.08 µg/g). The lower concentration of substrate available in the 
BFM thus hindered P. freudenreichii strains to grow and achieve high production 
vitamin  B12. Furthermore, the grains in the barley malt flour were germinated via 
malting process. During germination, Į- and ȕ-amylases convert the starch into 
simple sugars such as glucose (Delcour and Hoseney 2010), which was readily 
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utilized by the P. freudenreichii strains, explaining much higher vitamin B12 
concentrations produced in the fermented BMM.  
In the cobalt- and DMBI-supplemented SWP medium inoculated with the strain 3 
contained much lower vitamin B12 yields compared to the culture samples 
fermented  by  strain  1  and  strain  2  (Figure  15  and  18).  However,  in  cobalt-  and  
DMBI-added fermented BMM, strain 3 produced approximately equal level of 
vitamin  B12 yields to those produced by strain 2 (Figure 21). This may be 
influenced by the availability of riboflavin and niacin (vitamin B3/nicotinic acid) in 
the cereal grains. Hoerig and Renz (1980) found that although nicotinamide 
stimulated the transformation of DMBI from riboflavin, nicotinic acid seemed to be 
the true stimulating agent as no lag phase was observed when nicotinamide was 
replaced by nicotinic acid. Moreover, the lag phase was also omitted when P. 
freudenreichii was pre-incubated with nicotinamide that was completely split to 
nicotinic acid after 3 h of incubation (Hoerig and Renz 1980). Barley malt flour 
naturally contain riboflavin (0.22 mg/100 g) and nicotinic acid (6.4 mg/100 g) 
(Delcour and Hoseney 2010), the two precursors that are involved in DMBI 
formation by P. freudenreichii. Since the strain 3 was observed to produce 
maximum vitamin B12 yields with the addition of riboflavin/nicotinamide, the 
availability of riboflavin and nicotinic acid in barley malt flour may increase the 
vitamin B12 yields in cobalt- and DMBI- supplemented BMM.    
3.4.5 Vitamin B12 Quantification by Newly Developed UHPLC Method 
Microbiological assay (MBA) has been the official reference method in vitamin B12 
determination because of its high sensitivity and low-cost. However, MBA lacks of 
specificity as the indicator organism (L. delbrueckii ATCC 7830) may also react to 
vitamin  B12 analogues and other corrinoids that are not active in humans, giving 
discrepancy approximately 5-30% compared to chromatographic methods (Ball 
2005; Blake 2007). The HPLC/UV detection coupled with immunoaffinity 
extraction has been recently adopted for consideration as the future Official Method 
(AOAC Official First Action status) to determine vitamin B12 in selected food 
products (Campos-Giménez et al. 2008). However, the recently demonstrated 
UHPLC method offers quantification of vitamin B12 with higher chromatographic 
resolution and much shorter run time (Owen et al. 2011). Determined by the newly 
developed UHPLC method (Chamlagain et al. submitted), the maximum vitamin 
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B12 concentration in this study was 2.20 µg/mL, produced by the P. freudenreichii 
strain 3 in cobalt- and riboflavin/nicotinamide-supplemented SWP medium. This 
value  was  close  to  the  maximum vitamin  B12 production (2.5 µg/mL) achieved in 
the study done by Hugenschmidt et al. (2010). Almost all the samples analysed by 
MBA showed higher vitamin B12 contents than those measured by UHPLC method. 
Quantified by the MBA, high discrepancy up to 110.6% was observed in the 
fermented cereal samples, particularly in the samples that contained relatively low 
levels of vitamin B12 (Table 9). Since LC/UV usually lacks of sensitivity in 
detecting low quantities of vitamin B12 in food matrices (Viñas et al. 2003), the 
amount of vitamin B12 in the fermented cereal samples may influence the variance 
between the two methods. The observation was in accordance to a study done by 
Guggisberg et al. (2012), who reported a relative high factor between MBA- and 
HPLC-determined vitamin B12 yields in different meat products. Nevertheless, with 
sufficient  amount  of  vitamin  B12 concentrations in the samples, the newly 
developed UHPLC method is able to quantify low levels of vitamin B12 in food 
matrices.       
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4 CONCLUSIONS 
Utilizing an optimized process of 72 hours of anaerobic followed by 96 hours of 
aerobic fermentation without controlling the pH, this study achieved high production 
of vitamin B12 by P. freudenreichii strains, with maximum production of 2.20 µg/mL 
and 1.41 µg/g produced in supplemented whey permeate (SWP) medium and cereal 
matrices, respectively. However, since Propionibacterium cannot grow below pH 5.0, 
higher vitamin B12 production can be achieved with pH control at approximately 7.0 
in order to maintain the growth of the organisms (Martens et al. 2002). Furthermore, 
with the amount of vitamin B12 produced in the fermented cereal matrices, this study 
successfully demonstrated the possibilities to enrich plant-based foods with vitamin 
B12 through in situ fermentation.  
This study tested four different precursors that have been previously used in vitamin 
B12 biosynthesis: 5 mg/L cobalt (II) chloride, 15 mg/L DMBI, 15.05 mg/L riboflavin 
and 3.29 g/L nicotinamide. Cobalt  and DMBI are the two important parts that  build 
the  vitamin  B12 structure.  Thus,  their  presence  was  crucial  for  high  vitamin  B12 
production, shown by approximately 8-fold and 40-fold increase of vitamin B12 
yields in the fermented SWP medium and the cereal matrices, respectively, due to 
cobalt and DMBI supplementation. However, depending on the P. freudenreichii 
strains,  the  addition  of  DMBI  did  not  always  lead  to  maximum  vitamin  B12 
production, which was observed in the culture samples inoculated with the strain 3. 
The strain 3 produced maximum vitamin B12 yields  with  the  addition  of  
riboflavin/nicotinamide, the two precursors that are believed to be involved in DMBI 
biosynthesis. With the availability of riboflavin and nicotinic acid in cereal grains and 
the ability of the strain 3 to effectively transform riboflavin to DMBI, the strain 3 was 
the best P. freudenreichii strain to naturally produce vitamin B12 in plant-based food 
system. 
This  study  also  showed  that  the  optimum  vitamin  B12 production by the P. 
freudenreichii strain 3 with riboflavin/nicotinamide addition was significantly 
affected by the timing of adding the two precursors. Tested in the SWP medium with 
three different time points of riboflavin/nicotinamide supplementation (0, 72 and 144 
h), the optimum vitamin B12 production by the strain 3 was achieved when 
riboflavin/nicotinamide were added at the beginning of fermentation (0 h). The 
addition of riboflavin/nicotinamide at early stages could provide more time for the 
transformation  of  DMBI  from  riboflavin,  providing  more  DMBI  for  vitamin  B12 
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synthesis. Hence, higher concentration of vitamin B12 was produced. This study 
reflected the diversity of P. freudenreichii strains in producing vitamin B12 in the 
presence of different precursors. However, the exact mechanism of how these three 
strains utilized the precursors, in particular riboflavin and nicotinamide, to form 
DMBI was not well-understood. Therefore, it is prospective to further investigate the 
mechanism of P. freudenreichii strains in utilizing riboflavin and nicotiniamide in 
vitamin B12 biosynthesis.    
With a flow rate of 0.320 mL/min and 10-minute duration of each run, the 
quantification of vitamin B12 by the newly developed UHPLC method proved to be 
simple and fast. Compared to the standard microbiological assay, the vitamin B12 
concentrations in the fermented SWP medium measured by the UHPLC method 
presented satisfying values with expected discrepancy of 2-34%. However, higher 
discrepancy between the two methods was observed in the fermented cereal matrices, 
particularly in the samples that contained low levels of vitamin B12. This observation 
was in accordance to previous review about LC/UV methods that usually lack of 
sensitivity and specificity in detecting low quantities of vitamin B12 in food matrices. 
The newly developed UHPLC method was proven as a promising alternative method 
to quantify vitamin B12 in fermented plant-based food matrices.   
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